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CHAPTER I 
REVIEW OF THE LITERATURE 
1. Introduction 
1. 1. History of capillaroscopy 
Nailfold capillaroscopy is an imaging technique, 
which is used in medicine since 1823. In this year, 
Purkinje described skin capillaries when observing the 
nail-bed with a magnifying glass [99]. In 1911, Lombard 
has found that capillaries of the nailfold become visible 
for examination by microscope after placing a drop of 
immersion oil. 30 years ago, Maricq and Le Roy describe 
the specific capillaroscopic pattern in SSc. Since then the 
nailfold capillaroscopy has been found to be a non-
invasive, inexpensive, easy to repeat imaging technique, 
which is of considerable importance for the evaluation of 
microcirculation in vivo [19,33,34,35,37,38,89, 
90,92,123,126].  
 
1. 2. The cutaneous microcirculation 
 Cutaneous microcirculation consists of two 
horizontally-oriented plexuses.  The blood vessels of the 
underlying skeletal muscles and the subcutaneous fat 
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tissue form the deeply located plexus, which is located at 
the border between the skin and the subcutaneous layer. 
Ascendent arterioles and descendent venules connect the 
deep and the superficial plexus. The superficial plexus is 
located 1-1.5 mm under the skin surface. The capillary 
loops of the dermal papillae, which represent the 
nutritional part of the microcirculation, origin  from the 
superficial plexus. 1 to 3 capillary loops are located in 
each dermal papilla. In most areas of the finger, 
capillaries in dermal papillae are located in a 90° angle to 
the skin surface, so only the tip of the capillary loops can 
be seen with the form of a dot or a comma. These are the 
nutritional capillaries, which represent 15% of the 
cutaneous microcirculation. The rest 85% are used for 
thermoregulation. The function of the nutritional 
capillaries is to supply diffusion of oxygen and nutrients 
from the capillaries to the tissues. In the nailfold area, the 
capillary loops become more parallel to the skin surface, 
and in the last row they can be observed in their full 
length. The capillaries consist of an arterial and a venous 
part, and an apical loop, which connects these two. The 
arterial limb is narrower than the venous and the ratio of 
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the venous-to-arterial diameter is approximately 1.2 -
1.5:1 [19,21]. 
 
1. 3. Performing a capillaroscopic examination 
For visualization of the capillaries, a drop of cedar 
oil has to be placed on the nailfold. The patient is sitting 
with the hand at the heart level after a 15-20 minutes stay 
in a room with normal temperature of about 20-22°С 
[14,19,34,35,36,37,38]. The nailfolds of all ten fingers 
should be examined. However, the most precise 
morphologic evaluation is obtained at the fourth and fifth 
finger of both hands because of the highest transparency 
of the skin in these areas [34]. The following parameters 
are routinely evaluated: distribution, capillary shape, 
width, presence of dilated, giant capillaries, 
haemorrhages, avascular areas, neoangiogenic capillaries 
[14,19,37,38,44,69,78, 89,90,91,113].  
To consider capillaroscopic findings as abnormal, 
changes have to be observed at least in two fingers [34].  
 
1. 4. Equipment  
At the beginning, the nailfold capillaries are 
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examined with a light stereomicroscope that provides a 
magnification from 10x to 100x. For global evaluation of 
the vessels in the entire nailfold area, widefield 
capillaroscopy is used [19]. Other optical systems for 
visualization of capillaries (ophtalmoscopes, 
dermatoscopes) provide images with smaller 
magnification and lower quality, but they are useful, 
because they are a good alternative to perform 
capillaroscopic examinations in cases that require 
bedside examination [3,12,14,130]. However, digital 
videocapillaroscopy nowadays is a gold standard and 
consists of the combination of a microscope and a digital 
videocamera. It provides a significantly higher 
magnification from 50x to 1000x and it allows 
capillaroscopic parameters to be measured precisely. 
Several capillaroscopic parameters - width, length and 
capillary density may be measured quantitatively by 
special software programs [3,37,38,62], while others 
such as presence of haemorrhages, which are important 
markers for microangiopathy may be assessed 
qualitatively or semiquantitatively.  
  
  13 
2. Capillaroscopic parameters   
Using different capillaroscopic devices, the 
following capillaroscopic parameters can be examined: 
capillary diameter (width), capillary length, shape, 
distribution, mean capillary density, presence of 
avascular areas, haemorrhages, neoangiogenic capillaries 
[14,19,22,37,38,44,69,78,81,89,90,91,113]. Some of 
these parameters such as capillary width, length, mean 
capillary density can be exactly measured and precise 
quantitative examination can be performed by the current 
available software programs, while other parameters, e.g. 
shape, distribution and haemorrhages are evaluated 
qualitatively. Counting the number of the haemorrhages, 
ramified capillaries per mm and evaluation of the degree 
of the derangement are methods for semiquantitative 
analysis of the capillaroscopic image.  
а/ Capillary width  
For this capillaroscopic parameter different and 
contradictory values are reported in the literature. Some 
authors measure the width of the arterial and the venous 
capillary limb and the apical capillary loop, while others 
report values about the whole width of the capillary loop 
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[19,44,60,78,81,88,91,113]. The diameter of the arterial 
and the venous limb have to be measured in their widest 
part, the apical loop - in its central part, the whole width 
of the capillary loop - in its widest part. In fact, only the 
column of the red blood cells can be measured while the 
capillary wall is not visible. The reported values for the 
capillary width of the nutritive capillaries of the nailfold 
of the fingers vary between 6 and 15 µm for the arterial 
limb, and between 8 and 20 µm for the venous limb. 
Experimental studies have demonstrated that the real 
diameter is actually wider than those, which can be 
measured with 3.5-4.9 µm for the arterial limb and with 
3.8-5.4 µm for the venous limb. Mean capillary width is 
the mean value of the three widest capillary loops 
[44,69]. The upper normal limit for the whole width of 
the capillary loop is reported to be between 25 and 50 µm 
[35,59,65]. Maricq et al. have defined as giant capillaries 
those vessels that exceed the upper limit of the width of 
normal vessels 4 to 10 times [44,69,81]. The majority of 
authors classify as dilated capillaries, whose arterial 
diameter is wider than 15µm or the venous limb is wider 
than 20µm. And as giant capillary loops define 
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microvessels with diameter of either an arterial or a 
venous limb greater than 50µm [19,44,69,78,91,119].  
b/ Capillary length  
This is the distance between the bend of the 
capillary loop to its base, but it is sometimes difficult to 
define the second mark, because it depends on the skin 
transparency and this parameter inherits subjective 
variations [62]. Kabasakal et al. found mean values for 
this parameter in healthy adults of 250 µm and the upper 
normal limit of 300 µm [69]. Mean values, reported by 
Lеfford, for this parameter in healthy individuals are 
lower - 146 µm [81].  
c/ Distribution  
The normal distribution of the capillaries in the 
nailfold is regular and parallel [19]. Considering this, the 
degree of disarrangement is evaluated.  
d/ Shape  
The capillary loops in the most areas of the 
human body are perpendicular to the skin surface, while 
at the nailfold they become parallel to the skin surface. 
This allows to be visualized with their whole length. The 
normal shape of the capillaries of the nailfold is like 
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hairpin or the Latin letter U [19,119].  
e/ Mean capillary density  
This parameter reflects the number of capillaries 
per mm. Age-related changes of this parameter have to 
be considered. Most authors have found a tendency of an 
increase in mean capillary density during maturation. 
Aging is associated with a tendency of reduction of mean 
capillary density. Dolezalova et al. (2003) have found an 
increase of mean capillary density in healthy children. In 
17 healthy children and 20 healthy adults, the mean 
capillary density was 6.7 capillaries/mm in children and 
8.9 capillaries/mm in adults respectively [44]. Similar are 
the findings of the British authors (Herrick et al., 2000), 
who found a mean capillary density in 110 healthy 
children at the age between 6-15 years – 5 – 7.3 
capillaries/mm. The authors have found an increasing 
tendency for the arterial and the venous diameter with 
growing, without change in the values of the apical loop 
and mean capillary density  [60]. Cony et al. (1992) 
found a mean capillary density in healthy children – 9 
capillaries/mm and in adults - 10 capillaries/mm [31]. 
Different are the measured values for this parameter of 
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Italian authors (Martino et al., 1997) – 9 capillaries/mm 
in healthy children and 14 capillaries/mm in adults [93]. 
A large study has been conducted by Terreri et al. (1999), 
that includes 329 children at the age between 2.1 and 
16.7 years. The mean capillary density in this group was 
6.8-7.3 capillaries/mm. An increase in mean capillary 
density has also been observed during growing and only 
in the age group above 10 years the authors have found 
values for this parameter similar to those in adults [140]. 
f/ Avascular areas  
The avascular area is defined as a distance 
between two adjacent capillary loops from the distal rows 
greater than 500 µm or above 300 µm in the proximal 
area [119]. Avascular areas may be single or confluent 
[19]. For evaluation of the degree of capillary loss Lee et 
al. (1983) have proposed a 4 - stage scale: stage 0 - no 
avascular areas; stage 1 – mild capillary loss, that 
includes up to 2 avascular areas; stage 2 – moderate 
capillary loss with more than 2 avascular areas, stage 3 - 
severe loss of capillaries - frequent and confluent 
avascular areas [78]. Avascular areas often are 
surrounded by capillaries with disturbed distribution, 
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oriented towards the area of capillary loss [19]. 
g/ Presence of haemorrhages, thrombosis and 
extravasates 
Haemorrhages appear as extracapillary brown 
aggregations of erythrocytes with variable form and have 
to be differentiated from extravasates and thrombosis. 
The appearance of haemorrhages is an indicator of early 
vascular damage [19].  
h/ Neoangiogenesis  
It is a presence of newly formed vessels. 
Meandering capillaries, presence of more than one 
capillary loop in a single dermal papilla, ramified and 
bushy capillaries are the morphological substrate of 
neoangiogenesis [19,38,89,113].  
i/ Visibility of the subpapillary plexus 
Usually it is not visible, although in 30% of 
healthy individuals it may occur. The blood flow in the 
subpapillary plexus is slower in comparison with the 
capillary loops. When the blood flow  is abnormally 
slowed up, the subpapillary plexus is always visible and 
even prominent. In these cases of delayed blood flow, the 
finding is described as “dilated and prominent 
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subpapillary plexus”. The dilation of the venous 
(efferent) limb of the capillary loop and/or prominent 
subpapillary plexus provide both an evidence for a 
delayed blood flow [19]. 
j/ Other findings  
The presence of capillaries with crossed arterial 
and venous limbs (criss-cross forms, figure of eight) is a 
normal variant. This finding can be observed depending 
on the different angles of observation. Tortuous 
capillaries are also a normal variant, but only when they 
are less than 5% of all capillaries. “Increased tortuosity” 
is defined as presence of more than 10% tortuous 
capillaries of all capillaries [110].  
 
3. Age-related changes in capillaroscopic 
parameters  
As mentioned above the process of growing is 
related to an increase of mean capillary density, which is 
a part of maturation [44,140], while during aging a 
decrease of capillary density has been observed [72,126]. 
Li Li et al. (2006) examined 50 healthy women by 
videocapillaroscopy and laser Doppler and found a 
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tendency of reduction of capillary count during aging as 
well as an increase of intercapillary distance, capillary 
length, and visibility of the subpapillary plexus. In 
addition, an increased blood flow has been observed via 
capillaroscopy, which is explained with the process of 
age-related skin changes in the epidermis, which 
becomes thinner and more transparent. The reduced size 
and count of capillary loops is probably related to the 
age-related changes in metabolism, reduced oxygen 
supply, tissue hypoxia and is a part of the aging process. 
The increased capillary length may be related to the 
process of angiogenesis and the subpapillary plexus may 
possess a potential for remodeling [82,83,96]. Ingegnoli 
et al. (2005) examined 123 SLE patients and did not 
found a significant change in the values of 
capillaroscopic parameters in different age groups [67]. 
 
4. Key capillaroscopic parameters 
The key capillaroscopic parameters, which are 
indicators for microangiopathy, are giant capillaries, 
haemorrhages, avascular areas and neoangiogenic 
capillaries. The appearance of giant capillaries and 
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haemorrhages are parameters with a high positive 
predictive value for the development of CTD. The 
presence of tortuous capillaries is a variety of the normal. 
The elongation of capillary loop is not a sure marker for 
microangiopathy and short capillaries may be found in 
the cases with reduced transparency of the skin 
[19,33,34,35,37,38,42,69].    
 
5. Additional possibilities of nailfold 
videocapillaroscopy and other techniques for 
evaluation of microcirculation 
Besides native, fluorescent videocapillaroscopy 
also exists and is appropriate for detection of minimal 
microvascular abnormalities. In healthy subjects, there is 
a thin perivascular halo, while in SSc with secondary RP, 
there is an irregularly increased capillary permeability 
[19,126].  
Nailfold capillaroscopy, laser Doppler and power 
Doppler are methods for an evaluation of the 
microcirculation. Measurement of the systolic pressure of 
the digits and colour Doppler provides information for 
larger blood vessels – the digital arteries. Thermography 
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and plethysmography provide information for both 
microvessels and digital arteries. However, the nailfold 
capillaroscopy is the only method for evaluation of 
nutritional capillaries of the nailfold area [57,61,147]. 
 
6. Indication for performing capillaroscopy in 
rheumatologic practice 
The main indication for the capillaroscopic 
examination in rheumatology are the patients with RP, 
who are a common diagnostic problem in the 
rheumatologic practice. RP is caused by a reversible 
vasospasm of the small arteries and arterioles of the 
fingers and toes provoked by cold temperatures and 
emotional stress. It may affect also the nose, the tongue 
and other acral parts of the body. It manifests usually in 
three phases: ischemia, asphyxia and reactive hyperemia 
with skin discolouration from pallor to cyanosis and 
erythema. RP can be primary and secondary 
[11,17,19,34,36,38,63,64]. Secondary RP is a common 
sequela in a number of rheumatic diseases and nailfold 
capillaroscopy plays a key role in differentiation of 
primary and secondary forms of RP together with the 
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specific immunologic tests [14,31,33,34,35,36, 
37,38,48,50,52]. Current knowledge about this technique 
shows a characteristic pattern in secondary RP in the 
context of SSc and scleroderma-spectrum disorders. Its 
potential use has been studied also in other rheumatic 
disease e. g., SLE, SjÖgren syndrome, antiphospholipid 
syndrome, RA etc. [1,9,17,19,20,24,40,47,52,53,56, 
67,69,70,101,102,113,115,133,139,142] as well as in 
non-rheumatic diseases e. g., AH, diabetes mellitus etc. 
[5,6,7,28,48,105,112]. At present, capillaroscopy is still 
insufficiently applied in rheumatologic practice, rather by 
dermatologists or angiologists, thus prolonging the 
diagnostic process and increasing its cost. In addition, the 
lack of guidelines for performing capillaroscopy, the ill-
defined normal range of the capillaroscopic parameters, 
and the imprecise interpretation of the capillaroscopic 
patterns are the limiting factors for a widespread use in 
daily rheumatologic practice [55]. 
 
7. Capillaroscopic pattern in rheumatic 
diseases  
7. 1. Secondary RP  
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Older age of onset, clinical features for 
autoimmune disease, trophic alterations of the fingers, 
positive autoantibodies and abnormal capillaroscopic 
findings are the characteristic features of secondary RP in 
rheumatic diseases [33,84,122,132].  
 
7. 1. 1. Systemic sclerosis 
7. 1. 1. 1. Capillaroscopic pattern in the hands of 
systemic sclerosis patients 
RP is one of the most common symptoms in SSc 
with a frequency of approximately 90-95% and is usually 
the initial symptom, that precedes other features of the 
disease by years [17,87,122]. RP in SSc is severe and 
often presents with digital ulcers. The female to male 
ratio is 4:1 [122]. The capillaroscopic pattern in SSc is 
specific and is characterized by presence of dilated and 
giant capillaries, haemorrhages, avascular areas and 
neoangiogenic capillaries. It has been described for the 
first time by Maricq et al. (1980) and is called 
“scleroderma” type capillaroscopic pattern 
[12,19,34,35,36,37,38,39,89,90,91,92,124]. This specific 
capillaroscopic pattern is found in a great number of 
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cases with overt scleroderma (83-93%, Maricq) [37,90]. 
Bergman and co-workers found this type of specific 
capillaroscopic changes in 70.4% (19/27) of examined 
SSc patients [14], Nagy et al. in 87.5% of patients with 
diffuse SSc and in 61.6% of cases with limited form of 
the disease among 102 examined SSc patients [101]. 
Maricq et al. (1983) described two types of 
capillaroscopic changes in SSc – the “active” and ”slow” 
pattern. Extensive and confluent avascular areas and 
neovascularization is supposed to reflect activity and 
progression of the disease (so-called “active” 
capillaroscopic pattern). In contrast, the presence of giant 
capillary loops with minimal loss of capillaries is typical 
for the forms of the disease with a lower activity (so-
called “slow” capillaroscopic pattern) [19,90,127]. 
Maricq et al. found that some of the parameters of this 
pattern can also be observed in a group of disease from 
scleroderma spectrum disorders e. g. mixed connective 
tissue disease, UCTD, overlap syndromes, DM and have 
defined these findings as “scleroderma-like” 
capillaroscopic pattern [19,34,37,38,41,49,89, 
91,101,128,137]. 
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Cutolo (2000) described three phases of 
capillaroscopic changes in SSc: 
i/ an “early” phase- appearance of few dilated 
and/or giant capillaries and few haemorrhages. In this 
phase, the distribution is relatively preserved without loss 
of capillaries. These findings are of crucial importance 
for the early diagnosis of SSc. 
ii/ an “active” phase – there are high numbers of 
giant capillaries and haemorrhages. In addition, a 
moderate loss of capillaries, slight derangement and 
diffuse pericapillary oedema can be found. 
iii/ a “late” phase – it is characterized by severe 
loss of capillaries with extensive avascular areas, bushy 
and ramified capillaries, more than one capillary loop in 
a dermal papilla, which are the morphological substrate 
of the defective neoangiogenesis [35].  
The authenticity of the capillaroscopic changes in 
SSc has been confirmed histologically [127]. 
The capillaroscopic changes in SSc in the course 
of the disease is being explained by the action of 
different factors on angiogenesis. In the early stages of 
the disease, a pro-inflammatory state and an increased 
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production of vascular endothelial growth factor 
stimulate angiogenesis. As a result, capillaroscopic 
analysis of the nailfold bed demonstrates the presence of 
microhemorrhages and giant capillary loops. The short 
pro-angiogenic response is followed by a dramatic 
impairment of the angiogenic process. This switch is 
being explained by the action of antiangiogenic factors, 
which are thought to be markers for degradation of the 
extracellular matrix and other circulating proteins: 
angiostatin (a product of plasminogen cleavage), 
endostatin (of collagen XVIII), tumstatin (of collagen ІV) 
and canstatin (of A2, IV collagen). Local tissue hypoxia 
and increased level of hypoxia induced factor also 
contribute to the defective neoangiogenesis. As a result, 
in the following stages capillaroscopic examination 
reveals a reduced capillary density, followed by 
extensive avascular areas, areas of desertification, severe 
architectural derangement, neoangiogenic capillaries, 
which are a proof of an abortive vascular recovery 
[98,121,125]. 
A relationship between capillaroscopic changes 
and the type of SSc, its activity and the visceral organ 
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involvement has been proposed [19,25,26,35,36,39, 
73,90, 108,118], but not all authors do agree to this idea 
[78,86,141]. Severe capillary loss was noticed to be more 
common in patients with diffuse SSc. While dilated 
capillaries without loss of capillaries were found more 
frequently in patients with limited SSc - in 42% versus 
10.9% in patients with diffuse form of the disease among 
the examined 105 SSc patients (50 with limited SSc and 
55 with diffuse form) [108]. 
Cutolo et al. (2004) found in 241 SSc patients, 
that the presence of anti-topoisomerase antibodies (anti -
Scl-70) correlates with “active” and “late” 
capillaroscopic changes and probably accelerate the 
appearance of these findings. Positive ACA were 
observed to be more common in patients with an “early” 
phase capillaroscopic pattern and probably delay the 
development of “late” capillaroscopic changes [36]. 
Bredemeier and co-authors (2004) in 91 SSc patients 
ascertained a relationship between loss of capillaries in 
the nailfold beds, skin involvement and activity of 
pulmonary disease as evaluated by high-resolution 
computed tomography [22]. It has been suggested that 
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the dynamics of the alterations of the capillaroscopic 
pattern during the follow-up of patients with CTD could 
also be an indicator for visceral vascular involvement in 
the future [39,95,123]. 
At present, for the diagnosis of SSc the 
ARA/ACR criteria (1980) are used [94]. Nagy et al. 
found in 447 patients with CTD a high specificity of 
capillaroscopy for early diagnosis of SSc. An abnormal 
“scleroderma” type capillaroscopic pattern was found in 
patients who did not fulfil the ACR criteria. These 
patients presented with sclerodactyly, teleangiectasia, 
subcutaneous calcinosis, oesophageal dysmotility and 
other symptoms [101]. In 2001, Lonzetti et al. published 
a letter, in which the authors evaluated the sensitivity of 
the ACR classification criteria for SSc in a group of 259 
scleroderma patients. Using a regression tree analysis, 
they found that in limited SSc inclusion of the abnormal 
capillaroscopic pattern as a criterion would improve the 
sensitivity of the ACR criteria from 33.6 to 82.9%. 
Adding of clinically visible capillary telangiectasias, 
increased the sensitivity to 88.8%, and the presence of 
ACA increased it further to 91.5% [80,85,143]. Hudson 
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et al. (2007) also confirmed that inclusion of the specific 
capillaroscopic changes as a criterion improves 
sensitivity of ACR criteria for SSc [66]. The ACR 
classification criteria for SSc are specific rather than 
sensitive and by using these criteria, an incorrect 
diagnosis is unlikely. Of note, they have been proposed 
prior to the discovery of the specific for SSc 
capillaroscopic changes and autoantibodies. After 2000, 
three proposals for classification criteria of SSc have 
been published. The specific capillaroscopic pattern has 
been included in two of them – the criteria of Le Roy and 
Medsger (2001) and the other presented by Maricq and 
Valter (2004). Le Roy and Medsger (2001) and 
Nadashkevich et al. (2004) proposed also the inclusion of 
presence of RP as a diagnostic criterion for SSc 
[80,92,100,143]. The high prevalence of microvascular 
abnormalities in SSc underlines the potential of RP and 
capillaroscopic changes for early diagnosis of the 
disease. To improve the early diagnosis of SSc, Le Roy 
and Medsger proposed patients with RP and abnormal 
nailfold capillaroscopic changes or positive specific for 
SSc autoantibodies to be diagnosed as “prescleroderma” 
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or limited SSc even in the absence of other manifestation 
of the disease [80].  
 
7. 1. 1. 2. Capillaroscopic pattern and digital 
ulcers in systemic sclerosis  
Digital ulcers are common complication in SSc 
patients. Capillaroscopic findings for prediction of their 
development are not defined. Alivernini et al. (2009) 
speculated about a possible association between the 
development of ulcerations and the presence of avascular 
areas at the capillaroscopic examination [2]. Sebastiani et 
al. (2009) found a correlation between capillaroscopic 
changes and the development of digital ulcers in 120 SSc 
patients. A significant association between presence of 
digital ulcers and the lower number of capillaries in the 
distal row, as well as with higher number of 
megacapillaries and higher loop diameter was observed. 
A capillaroscopic index for prediction development of 
digital ulcers in SSc patients has been proposed [120].  
 
7. 1. 1. 3. Foot involvement in systemic slcerosis 
La Montagna et al. (2002) examined the 
  32 
involvement of the feet in 100 SSc patients and 
monitored these patients between 1 and 28 years (median 
range 7 years). Among the 100 SSc patients included in 
the study, 90% presented with features of RP of the feet 
versus 100% with RP of the hands. In 43% of the cases 
from this group, RP of the feet was presented at initial 
evaluation, while 47% developed it in the course of the 
follow-up. RP of the hands was registered in 100% of 
patients at the initial evaluation. The onset of clinically 
evident involvement of the feet was noted to occur later 
in limited SSc than in the diffuse form of the disease. 
Lower rates of necrotizing RP, tendon friction rubs and 
skin thickening scores were found in the feet of patients 
with SSc as compared with the hands, whereas 
arthralgias affected significantly more often the feet. 
Acroosteolysis, calcinosis and erosions were observed 
significantly more often in the hands of SSc patients. The 
authors concluded, that the involvement of the feet in 
SSc appears to be less frequent and with later onset, but 
can be similarly disabling [76]. 
In contrast to the now widely used microscopic 
examination of the nailfolds of the fingers, at present this 
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technique is not established for feet examination in the 
everyday rheumatologic clinical practice. 
In 84 healthy subjects, Noy Delcourt et al. (1986) 
observed that the majority of the feet parameters are 
similar to those of the hands e. g., shape and capillary 
width. For other parameters the authors found some 
differences, such as a smaller number of capillary loops 
per mm, greater number of minor dystrophic forms, 
shorter capillary loops at the feets as compared with 
hands. In addition, in the feet of the examined healthy 
individuals, the more frequent findings as compared with 
hands were the irregularity in the distribution of the 
capillary loops and a peri-capillary haziness, which is 
associated with the physiological oedema of the feet. No 
major dystrophy was seen and traumatic hemorrhages 
were also not more frequent in the toes than in the fingers 
[106].  
 
 7. 1. 2. Systemic lupus erythematosus  
The prevalence of RP in SLE is reported to be 
ranging from 10 to 45% and it usually indicates a more 
benign course without tissue necrosis [17,74]. 
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Capillaroscopic pattern in SLE is less specific in 
comparison to SSc and the other above mentioned 
diseases, in which “scleroderma-like” capillaroscopic 
pattern may be presented [19,40]. Nailfold 
capillaroscopic changes in SLE include a wide range. 
According to some investigators, the majority 
capillaroscopic findings are non-specific [81]. The most 
frequent described specific changes in SLE are tortuous, 
meandering capillaries and bizarre-formed loops [113], 
an increased length of capillaries [52,69], an increased 
diameter [113] and a prominent subpapillary plexus 
[52,69]. In a part of the studies, these changes specific for 
SLE have been termed “SLE” type capillaroscopic 
pattern. Increased tortuosity can be found in 42% of SLE 
patients, but in only 6% of SSc patients [14,52,113].  
The “scleroderma-like” capillaroscopic picture 
with dilated, giant capillaries, haemorrhages and 
avascular areas is a rare finding in SLE in contrast to 
other CTD. The frequency of the latter pattern is low, 
ranging from 2% to 9% [14,69,90,101] and slightly 
higher, reported by Furtado - 15% [47]. A number of 
investigators have found a correlation between 
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“scleroderma-like” capillaroscopic pattern and the 
presence of RP and anti-U1-RNP antibody. This finding 
is being explained with a potential subclinical overlap 
with SSc [47,56,67,81,89].  
Data addressing the association between abnormal 
capillaroscopic findings and positive anticardiolipin 
antibodies are contradictory. It has been found a lack of 
correlation [67], a negative correlation [47], and a 
positive association [20,115]. The following mechanism 
could be proposed for the pathogenetic effect of anti-
phospholipid antibodies on microcirculation: direct 
damage of endothelial cells through upregulation of 
adhesion molecules, platelet activation, interaction with 
elements of the coagulation system and activation of the 
complement components. The relationship between 
microangiopathy and the presence of antiphospholipid 
antibodies could be explained by this cascade of 
pathologic changes [9,115].  
A correlation between the abnormal 
capillaroscopic pattern and other SLE specific 
autoantibodies (anti-dsDNA, anti-Sm) [115] could be 
found, as well as with the disease activity evaluated by 
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different disease indices (SLEDAI, ECLAM) [67,115]. 
Besides, an association of abnormal capillaroscopic 
findings, especially a decreased capillary density and a 
reduced diffusion capacity, could be verified. It was 
speculated that the reduced number of capillaries in the 
nailfold area may be an indicator for pulmonary capillary 
loss [56,109]. Nailfold capillaroscopy is thought to be 
useful for the evaluation of microcirculation in SLE 
patients especially in those with secondary RP. 
 
7. 1. 3. Undifferentiated connective tissue 
disease 
The term UCTD is used to describe a group of 
patients with features of systemic autoimmune disease, 
that lacks the characteristics of a well-defined rheumatic 
disorder. Some of these patients (1/4 to 1/3) develop a 
distinct rheumatic entity during the follow-up, the most 
frequent being SSc, SLE, RA and SjÖgren’s syndrome, 
but the majority of patients remain in a stable clinically 
and laboratory condition in the scope of the term UCTD. 
Nagy et al. found a “scleroderma-like” capillaroscopic 
pattern in 13.8% of 65 patients with “UCTD” [101]. 
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7. 1. 4. Inflammatory arthritis 
7. 1. 4. 1. Rheumatoid arthritis  
The prevalence of RP in RA is not well-defined. 
Some authors consider that such an association is quite 
rare [122]. On the other hand, other authors include RA 
among the rheumatic diseases associated with RP 
[17,79]. Grassi et al. (1994, Italy) found a low incidence 
of RP in RA - 4.6 %, (19/411). The higher prevalence of 
RP in men with RA (7.5%) than in women (3.2%) was 
interesting. In comparison, in a cohort of 919 patients 
with osteoarthritis, a global tendency of a female 
predominance of RP was observed. The higher 
prevalence of RP in men with RA has been explained by 
the authors with a higher association of RA with 
secondary vasculitis in men [54]. These results are in 
agreement with the findings of Carrol et al. (1981, North 
Australia), who found a manifestation of RP in 2.7% оf 
141 patients with RA [27]. In а French population of RA 
patients, Saraux and co-workers found а higher 
prevalence of RP in RA (17.2%, 54/322) [117]. The 
contradictory literature data about the prevalence of RP 
in RA require future studies in different populations of 
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RA patients. 
In 31 RA patients, Redisch and co-authors found 
the following abnormal capillaroscopic findings: 
elongated capillaries, increased tortuosity, prominent 
subpapillary plexus. A “scleroderma-like” pattern was 
not observed in RA patients [53,113]. A correlation 
between abnormal capillaroscopic pattern and increased 
levels of fibrinogen and other acute-phase reactants 
(CRP, ESR) could be found in patients with primary and 
secondary RP [131].  
 
7. 1. 4. 2. Psoriatic arthritis  
The first observation of capillaroscopic findings 
in PsA was performed by Redish еt al. (1970), using light 
microscope. The most frequent capillaroscopic changes 
were meandering capillaries and tight terminal 
convolutions [113]. In PsA patients with nail 
involvement, independent of presence or absence of 
arthritis of distal interphalangeal joints, a lower mean 
capillary density has been found as compared with 
healthy controls. In PsA patients with distal 
interphalangeal joints involvement, independent of the 
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concomitant nail damage, a decreased diameter of the 
arterial and the venous limb of the capillary loop has 
been observed [16]. In an Italian study, a decreased 
capillary diameter and length in RA-like form of PsA 
was reported [116].  An  association between psoriasis, 
PsA and RP is reported as individual cases as well as 
association of psoriasis and PsA with autoimmune 
disease like SSc, SLE, etc. Of note, systemic studies in 
the current literature addressing the frequency of RP in 
PsA are not available [58,114]. 
 
7. 1. 4. 3. Early arthritis 
 According to the EULAR recommendations 
(2007) for the management of early arthritis, exclusion of 
diseases other than RA requires careful medical history, 
clinical examination, and at least the following laboratory 
tests: complete blood cell count, urine analysis, 
transaminases and ANA test. These investigations are 
necessary to differentiate RA from other rheumatic 
diseases such as CTD, reactive arthritis etc. because of 
the different prognosis and treatment [32]. The role of 
capillaroscopy in early arthritis has not been studied and 
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discussed in the current rheumatologic literature 
including in the above mentioned EULAR 
recommendations.  
  
7. 1. 5. Other rheumatic diseases  
 7. 1. 5. 1. Primary RP 
 The diagnosis of primary RP can be made in these 
cases, in which no underlying causes for development of 
the vasospastic disorder can be identified. Women are 4 
to 20 times more likely than men to develop primary RP. 
The onset of the disease is usually at puberty and is more 
frequent in certain families. Symmetrical vasospastic 
attacks and a benign course without trophic lesions is 
typical [17,63,122,132,135]. Primary RP is often 
associated with migraine, retinopathy and Prinzmetal’s 
angina. This supports the hypothesis that RP is a 
systemic disorder with spasms not only of the peripheral 
arteries, but also with spasms of the coronary vessels, the 
arterioles of the lung, the brain, the retina and the 
gastrointestinal tract [75,129,135].  
The absence of an abnormal capillaroscopic 
pattern is one of the diagnostic criteria for primary RP. 
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For the diagnosis of primary RP, the lack of the 
following criteria (Le Roy and Medsger) is required  
а/ digital ulcerations and gangrenes b/ elevated ESR;  
c/ positive test for ANA with a high titer d/ abnormal 
capillaroscopic pattern [79]. Capillaroscopic pattern in 
primary RP is not specific and the demonstrated 
capillaries are normal in number and size. The mean 
capillary diameter, capillary density and capillary 
morphology do not differ significantly from those of 
healthy subjects. The capillary diameter can be slightly 
enlarged, but it does not have a diagnostic value [19]. In 
primary RP patients, Bukhari et al. [23] and Anderson et 
al. [4] found enlarged capillary loops when compared 
with healthy subjects, which suggests minimal 
microvascular abnormalities. In a part of primary RP 
patients without signs and symptoms of a CTD, 
capillaroscopic pattern may be abnormal [90,101]. 
Primary RP patients with abnormal capillaroscopic 
changes may develop a connective autoimmune disorder 
[23,90]. Even the detection of a single loop with diameter 
> 50μm should be considered as a potential marker of 
microangiopathy and an indicator for future development 
  42 
of CTD. It has been suggested that the appearance of 
dilated capillaries is due to a local response to tissue 
hypoxia [34,37,38]. Blockmans et al. found enlarged 
capillaries in 100% of SSc patients, 56% of patients with 
mixed connective tissue disease, and 86% of DM patients 
[18,34]. RP may be an isolated complaint or a first 
symptom of CTD, so patients with manifestation of RP 
have to be regularly examined [34,110,122,132,148]. 
Over a 10-year follow-up period, the frequency of 
development of connective autoimmune disease is 
increasing from 5 to 19% [110,148]. The capillaroscopic 
pattern of the same digit remains surprisingly constant 
for an extended period of time in healthy individuals, 
while appearance of abnormal findings inherits a positive 
predictive value of 47% for the development of CTD. In 
combination with a positive ANA test and the presence 
of a RF, the predictive value increases up to 55% [74]. 
 Therefore, nailfold capillaroscopy is of crucial 
importance for the differentiation of primary and 
secondary RP in rheumatic diseases particularly the 
scleroderma - spectrum disorders. In presence of RP, a 
follow-up nailfold capillararoscopic analysis is 
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recommended to be performed every 6 months 
[17,19,37,38,68,71]. 
  
7. 1. 5. 2. Primary fibromyalgia 
Fibromyalgia is an idiopathic, chronic, 
nonarticular pain syndrome defined by widespread 
musculoskeletal pain and multiple tender points [43,146]. 
Secondary fibromyalgia is a common finding in most 
rheumatic diseases e. g., RA, SLE, Sjögren syndrome 
[145].  
RP is a common finding in patients with primary 
and secondary fibromyalgia and occurs in about 30% of 
patients [77,146]. However, capillaroscopic changes in 
fibromyalgia are not specifically studied and are not 
well-defined in the current literature. Frödin et al. (1988) 
published their observation on 10 patients with primary 
fibromyalgia. The authors have found moderate 
enlargement of the capillary loops in the examined group 
of patients [46]. Morf et al. (2005) found in 10 women 
with fibromyalgia significantly fewer capillaries in the 
nailfold area and more capillary dilations in comparison 
with age- and sex-matched controls [97].  
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7. 1. 5. 3. Paraneoplastic RP 
The association of cancer with autoimmune 
phenomena is well known in different rheumatic diseases 
such as PM/DM, Sjögren’s syndrome, inflammatory 
arthritis, SLE, RP, hypertrophic osteoarthropathy, 
polymyalgia rheumatica, SSc, scleroderma-like 
syndromes [13,15,29,103,104]. Rheumatic disorders 
associated with cancer include different manifestation, 
most of which have no features distinguishing them from 
idiopathic rheumatic diseases. Neoplastic lesions may 
evoke the paraneoplastic rheumatic syndromes or to be a 
complication of the chronic rheumatic diseases or its 
treatment. They may precede the clinical manifestation of 
the neoplasm, occur concomitantly or after its diagnosis 
[29,103]. Maurice Raynaud (1862) and Trousseau (1865) 
described the association between malignancies and 
peripheral blood vessel diseases. Ischemia of the fingers 
has been reported in patients with carcinomas of the 
breast, stomach and the esophagus, in leukemia patients 
and in patients with other malignancies. This 
phenomenon is caused by the secretion of vasoactive 
substances by the tumor cells and the respective immune 
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response of the organism. A newly appeared RP with a 
late onset after the age of 60 may be a key hint for an 
underlying malignancy [84,111]. RP may be an isolated 
symptom or a manifestation in the context of a 
paraneoplastic rheumatic syndrome. However, the 
capillaroscopic pattern in paraneoplastic RP has not been 
studied and defined in the current literature.  
 
8. Capillaroscopic changes in arterial 
hypertension 
In essential AH patients, a rarefaction of 
capillaries of the nailfold and the forearm is found as 
well as tendency to vasospasm. The changes are 
structural rather than functional [5,51,112]. In patients 
with established disease, Gasser and Prassad announce 
similar data for a capillary reduction of 15-20% [51,112]. 
Analogous changes are observed in conjunctival vessels 
[126]. A correlation between the mean capillary density 
and the values of diastolic blood pressure could be 
observed [5]. A capillary rarefaction has also been found 
in borderline essential AH [6]. A reduced capillary count 
precedes development of AH and is found in healthy 
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subjects with predisposition to high blood pressure, who 
are offsprings of AH patients. This suggests that 
microvascular abnormalities in AH patients are primary, 
probably genetically determined [7,105]. It is 
hypothesized that reduced capillary count in hypertensive 
subjects is a result of defective angiogenesis. These 
patients are usually born with lower birth weight and are 
more obese than normotensive controls. Probably, 
because of faster rates of growth in later life, in 
hypertensive subjects more capillaries have to be 
recruited to supply perfusion. This probably results in 
structural microvascular changes and AH [10,105]. The 
available studies address AH patients, who do not receive 
antihypertensive therapy. There are sparse data about 
microvascular findings in treated patients. Weinbacher et 
al. (1994) after 6 weeks' treatment with 5 mg cilazapril 
plus 12.5 mg hydrochlorothiazide did not found 
significant changes in morphological capillaroscopic 
parameters in 17 AH patients [144]. 
 
9. Analysis of the capillaroscopic images   
As mentioned above, some of the capillaroscopic 
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parameters such as capillary width, length, mean 
capillary density can be exactly measured quantitatively 
by the current available software programs, while other 
parameters e.g., shape, distribution and haemorrhages are 
evaluated qualitatively. Counting the number of the 
haemorrhages, ramified capillaries per mm and 
evaluation of the degree of the derangement are methods 
for semiquantitative analysis of the capillaroscopic 
image. Nowadays, there are no guidelines for the 
application of the qualitative and quantitative analysis of 
the capillaroscopic images in the rheumatologic practice 
[91,107,119].  
Sulli et al. (2008) offered an index for 
semiquantitaive assessment of capillaroscopic changes in 
SSc. The examined fingers are 2
nd
, 3
rd
, 4
th
 and 5
th
. The 
following capillaroscopic parametrs were evaluated – 
dilated, giant capillaries, haemorrhages, loss of 
capillaries, disarrangement, capillary ramification. A 
four-degree scale 0-3 was used for rating. The authors 
suggested the nailfold area to be divided in 4 fields each 
with 1 mm length, oriented according to the middle of the 
nailfold. The sum of the eight examined digit at the end 
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is divided to 8 and this result is the mean score of the 
capillaroscopic image. 90 SSc patients were evaluated by 
nailfold videocapllaroscopy for an average of 72 months. 
The capillaroscopic score was found to be a sensitive tool 
to quantify and monitor the SSc microvascular damage 
[134]. 
 
            10. State of the art and actuality of the subject 
Several conclusions may be made from the 
analysis of the current literature. The nailfold 
videocapillaroscopy is currently used particularly for the 
diagnosis of SSc, differentiation of primary RP and 
secondary RP in SSc and scleroderma-spectrum 
disorders. Although its potential for differentiation of RP 
in different forms of secondary RP in rheumatic diseases 
is suggested, it is still insufficiently applied for that 
reason in clinical rheumatological practice.  
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Conclusions 
1. Nailfold capillaroscopy is a non-invasive, 
inexpensive, easy to repeat imaging technique, which is 
of considerable importance for the evaluation of 
microcirculation in vivo with high reproduction and low 
price.  
2. The main indication for the investigation in 
rheumatology are patients with RP, who are a common 
diagnostic problem in rheumatologic practice. The 
method is of crucial importance for the diagnosis and the 
differentiation of primary RP from secondary RP in SSc 
and scleroderma-spectrum disorders, which is of crucial 
importance because of the different severity, prognosis 
and therapeutic approach. Thus, capillaroscopic 
examination should be performed in all patients with RP 
even when there are no clinical and laboratory evidence 
for CTD, because the abnormal capillaroscopic pattern 
inherits a high positive predictive value for the 
development of systemic rheumatic disease.  
3. The inclusion of the abnormal capillaroscopic 
pattern as a diagnostic criterion in patients with SSc 
increases the sensitivity of ACR classification criteria for 
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SSc and improves the possibilities for early diagnosis of 
the disease.  
4. There are no data about the capillaroscopic 
pattern of the feet in SSc patients.  
5. The absence of an abnormal capillaroscopic 
pattern is one of the diagnostic criteria for primary RP.  
6. Interestingly, a correlation between 
capillarosopic pattern and clinical presentation, 
laboratory findings and disease activity may indicate 
common pathways.  
   7. There are limited data about capillaroscopic 
findings in patients with rheumatic diseases without RP 
e. g., SLE, UCTD, inflammatory arthritis, fibromyalgia.
  
8. AH is a co-morbidity in a high number of 
patients with rheumatic diseases. In the current literature, 
it has been known that low mean capillary density can be 
found in different regions of the body in these patients. 
This phenomenon has been observed also in the area of 
the nailfold of patients, who are not treated with 
antihypertensive drugs. Sparse data about capillary 
density in the nailfold area in patients treated with 
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antihypertensive drugs exist.  
9. No guidelines for the application of the 
qualitative and quantitative methods for analysis of the 
capillaroscopic images in rheumatologic practice exist.  
 These conclusions stimulated the work presented 
in this dissertation. 
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CHAPTER II 
AIM AND TASKS OF THE DISSERTATION 
            1. The objective of the dissertation 
To establish a more detailed view on the role of 
capillaroscopy in different unclear rheumatologic 
settings.   
 
2. Tasks 
1. Studying the role of capillaroscopy in SSc. 
1. 1. Confirmation of the known specific 
capillaroscopic pattern in SSc. 
1. 2. Studying the association between 
capillaroscopic pattern and the presence of digital ulcers. 
1. 3. The high specificity of capillaroscopic 
pattern in SSc raised the question about presence of 
microvascular changes in the nailfolds of the toes. 
2. Studying the role of capillaroscopy in other 
common CTD. 
2. 1. Role of capillaroscopy in SLE. 
2. 1. 1. Studying the association of capillaroscopic 
pattern in SLE patients with the immunologic profile. 
2. 2. Role of capillaroscopy in UCTD. 
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3. Studying the role of capillaroscopy in 
inflammatory arthritis.  
3. 1. Role of capillaroscopy in RA with and 
without RP. 
3. 2. Role of capillaroscopy in PsA. 
3. 3. Role of capillaroscopy in early arthritis. 
4. Role of capillaroscopy in other rheumatic 
diseases. 
4. 1. Role of capillaroscopy in primary RP. 
4. 2. Role of capillaroscopy in primary 
fibromyalgia. 
4. 3. Role of capillaroscopy in paraneoplastic RP. 
5. Role of capillaroscopy in AH.  
6. Comparison of the qualitative and quantitative 
analysis of key capillaroscopic parameters in patients 
with common rheumatic diseases e. g., SSc, SLE, UCTD, 
different forms of overlap, RA and primary RP.  
Assessment of the reproducibility of the 
qualitative evaluation of the capillaroscopic parameters, 
performed by two different investigators. 
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CHAPTER III 
MATERIALS AND METHODS. INCLUSION 
AND EXCLUSION CRITERIA 
1. Patients 
The study includes 297 patients with rheumatic 
diseases, who were examined during routine in- and 
outpatient consultation in the Department of 
Rheumatology and Clinical Immunology in Kerckhoff 
Clinic, Bad Nauheim. The examined patients are from 
the following groups:  
1. 36 patients with SSc, diagnosed according to 
the current ACR classification criteria, 1980 [94], 30 
patients with limited SSc, 5 with diffuse SSc and 1 with 
overlap syndrome, 30 female and 6 male patients, mean 
age 56±14 years. The severity of RP in the hands and feet 
was assessed with VAS (100mm) by the physician and 
the patient. The patients were asked by the physician - 
“please, evaluate the severity and frequency of RP in the 
last month according to the disability that vasospastic 
attacks cause to your everyday activities“. The presence 
of digital ulcers of the hands and the feet was 
documented. The skin score of the fingers and feet was 
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assessed by the scale used for evaluation of the modified 
Rodnan skin score: 0 - uninvolved skin, 1-mild, 2-
moderate, 3-severe thickening [30].  
2. 30 female patients with SLE according to the 
current ACR classification criteria, 1982 [136]. The mean 
age of the SLE patients was 49±15.4 years.  
3. 31 patients with UCTD. This group of patients 
manifested with signs of CTD, but did not fulfill the 
criteria for SSc, SLE or other definite CTD. The mean 
age of the patients from this group was 50±17 years, 30 
females and 1 male. 
4. 62 patients with RA according to the current 
ACR classification criteria, 1987 [8]. The mean age of 
patients from RA group was 62.8±11.3 years, 47 females 
and 15 males. 
 5. 9 female patients with early arthritis, at the time 
of their first referral to a rheumatologist, with duration of 
symptoms < 6 months, who did not fulfill the criteria for 
a definite type of arthritis or CTD and are diagnosed 
during the follow-up as RA. The mean age of this group 
was 46.44±13.8 years.  
6. 34 patients with RA-like form of PsA and with 
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subtype of the disease with involvement of the distal 
interphalangeal joints, who fulfilled the CASPAR criteria 
[138]. The mean age was 49±12.04 years, 22 females and 
12 males. 
7. 31 patients with primary RP according to the 
classification criteria of Le Roy and Medsger, 1992 [79]. 
The mean age was 47±14years, 23 females and 8 males.  
 8. 26 patients with primary fibromyalgia 
according to the current ACR classification criteria, 1990 
[146]. The mean age was 55±10 years, 25 females and 1 
male.  
9. Paraneoplastic RP – 3 patients.  
 10. 35 patients with essential mild-to-moderate 
AH without systemic rheumatic disease on a regular 
antihypertensive treatment. The mean age was 
62.6±11.92 years, 22 females and 13 males.  
11. A control group - 43 healthy volunteers 
without known disease, who did not receive medications. 
Comparison of the capillaroscopic parameters was made 
with age- and sex-matched healthy controls, who were 
specifically chosen for each group of patients.  
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2. Technical equipment 
Nailfold capillaroscopy was performed using a 
high-end videocapillaroscope Videocap 3.0 (DS Medica, 
Italy). Measurements were performed with the software 
programme of the device and all the measurements were 
made in mm, (0.001mm=1µm). The following 
capillaroscopic parameters were evaluated:  
1) distribution 
2) shape of capillaries 
3) diameter of the arterial limb of the capillary loop 
4) diameter of the venous limb of the capillary loop 
5) capillary length 
6) mean capillary density 
7) presence of avascular areas 
8) presence of haemorrhages 
9) presence of neoangiogenic capillaries 
10) visibility of the subpapillary plexus. 
 As dilated were classified capillaries with a 
diameter of the arterial limb wider than 0.015mm 
(=15µm) or a venous limb wider than 0.020mm 
(=20µm). As giant capillary loops were classified 
microvessels with diameter of either an arterial or a 
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venous limb greater than 0.050mm (=50µm). The mean 
diameter of the arterial and the venous limb was 
calculated as a mean value of the three widest arterial, 
respectively venous limbs at their widest part. The length 
of the capillary loop was measured as the distance 
between the papillary plexus (if visible) or the visualized 
base of the capillary loop and the apical part. The mean 
capillary length was calculated as a mean value of the 
three longest capillaries. As elongated were classified 
capillary loops with lengths longer than 0.300mm 
(=300µm). The haemorrhages are the extracapillary 
brown aggregations of erythrocytes. The mean capillary 
density was calculated as a number of capillary loops in 
the distal row per 1 mm. The avascular area was defined 
as a distance between two adjacent capillary loops from 
the distal rows greater than 0.5mm (=500 µm) or above 
0.3mm (300 µm) in the proximal area [119]. Meandering 
capillaries, presence of more than one capillary loop in a 
single dermal papilla, ramified and bushy capillaries are 
the characteristic features of neoangiogenic capillaries 
and were classified respectively. All observations are 
performed with the subjects in a constant temperature 
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setting (22°  to 25° C). 
  
3. Immunologic tests  
In the group of patients with SLE, the following 
immunologic tests were examined: ANA 
immunofluorescence test and antibodies against 
extractable nuclear antigens e. g., anti-dsDNA, anti-Ro, 
anti-La, anti-Sm, anti-RNP, anticardiolipin IgG, 
anticardiolipin IgM, anti-β2-glycoprotein (IgG, IgM), 
measured by ELISA method.  
 
4. Other methods 
200 capillaroscopic images from 93 patients with 
different rheumatic diseases were analysed quantitatively 
and qualitatively by two different investigators. The 
distribution of the images according to the diagnosis and 
the microvascular abnormalities was as follows - group 
1: 73 images from SSc patients (“scleroderma” type), 
group 2: 10 images from DM (“scleroderma-like”), group 
3: 25 images from UCTD and different forms of overlap 
(19 “scleroderma-like“), group 4: 26 from SLE, group 5: 
46 from RA and group 6: 20 from primary RP. All the 
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images were mixed and blindly presented to both 
investigators.  
The following major capillaroscopic parameters 
were evaluated: presence of dilated and giant capillaries, 
haemorrhages, avascular areas. The above mentioned 
definitions were used e. g., capillaries with a diameter of 
the arterial limb wider than 0. 015mm (= 15µm) or a 
venous limb wider than 0.020mm (=20 µm) were 
classified as dilated. As giant capillary loops were 
classified microvessels with a diameter of either an 
arterial or a venous limb wider than 0.050mm (=50 µm) 
and as elongated – capillaries with length greater than 
0.300mm (=300). The avascular area was defined as a 
distance between two adjacent capillary loops from the 
distal rows longer than 0. 500mm (=500 µm) or above 
0.300mm (=300 µm) in the proximal area [117]. The 
reliability of quantitative and qualitative methods, and 
the reproducibility of the qualitative assessment 
performed by two different investigators was evaluated 
specifically for the “scleroderma” and “scleroderma-like” 
images and for images of primary RP patients.  
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i) For comparison of the quantitative and 
qualitative methods, investigator 1 assessed presence of 
dilated, giant capillaries and avascular areas, according 
to the above-mentioned definitions by the available 
software programme and his estimates were compared 
with the results of investigator 2, who assessed the 
parameters qualitatively.  
 
ii) For evaluation the reproducibility of the 
qualitative method performed by two different 
investigators, the mixed and blindly presented 
capillaroscopic images, were evaluated qualitatively by 
the investigator 1 and investigator 2  for the presence of 
the following capillaroscopic changes - dilated 
capillaries, giant capillaries, haemorrhages and 
avascular areas.  
 
5. Statistical methods 
For statistical analysis of the data, variational 
analysis, t-criterion of V. Goset (Student-Fisher) and -
square test were used. Results are shown as mean 
value/average  SD. The values of p<0. 05 were 
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considered as statistically significant.  
The study has been approved by the local ethical 
committee and all patients signed an informed consent. 
 
6. Inclusion and exclusion criteria 
6. 1. Inclusion criteria 
1. SSc according to the current ACR classification 
criteria, 1980 [94]. 
2. SLE according to the current ACR 
classification criteria, 1982 [136]. 
3. Patients with UCTD are defined as having 
features of systemic rheumatic disease, but who did not 
fulfill the accepted diagnostic criteria of a distinct 
rheumatic disease.  
Patients with overlap syndrome are referred to the 
entity, which dominated at clinical presentation.   
4. RA according to the current ACR classification 
criteria, 1987 [8]. 
5. PsA according to the CASPAR criteria [138]. 
6. Patients with early arthritis. at the time of their 
first referral to a rheumatologist, with duration of 
symptoms < 6 months, who did not fulfill the criteria for 
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a definite type of arthritis or CTD. 
7. Primary RP according to classification criteria 
of Le Roy and Medsger, 1992 [79].  
8. Patients with primary fibromyalgia according 
to the current ACR classification criteria, 1990 [146]. 
9. Healthy controls - employees from the hospital 
and their relatives. 
 
Comparison of the capillaroscopic parameters was 
made with age- and sex-matched healthy controls, who 
were specifically chosen for each group of patients. The 
data of the patients and the age- and sex-matched healthy 
controls are shown in Table.1. 
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Table. 1. Number, age and sex of the included groups of 
patients and the age- and sex-matched controls.  
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6. 2 Exclusion criteria 
 Exclusion criteria for healthy controls group was 
history of vasospasm, rheumatic or other known diseases, 
taking any medications. Specific history for familial 
predisposition for AH in first degree relatives was 
undertaken and it was included also as an exclusion 
criterion. Defective angiogenesis in obesity was also 
taken into account and body mass index above > 25kg/m
2 
was included also as an exclusion criterion for this group. 
In 22 of the healthy individuals, we performed 
capillaroscopic examination of the toes. Here, the 
presence of chronic arterial or venous insufficiency were 
additional exclusion criteria. 
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CHAPTER IV 
RESULTS 
1. Systemic sclerosis 
1. 1. Capillaroscopic pattern of the hands in 
systemic sclerosis patients 
 RP was found as clinical symptom in 100% 
(36/36) of the examined SSc patients. “Scleroderma” 
type capillaroscopic pattern with dilated and giant 
capillaries, haemorrhages, avascular areas and 
neoangiogenesis was found in 97.2% (35/36) of the 
cases.  
The mean diameters of the arterial 
(0.035±0.013mm) and the venous limb (0,053±0,021mm) 
in SSc were significantly wider as compared with the 
respective values in healthy controls (0.012±0.001mm 
for the arterial limb and 0.017±0.001mm for the venous 
limb), (p<0.05). The mean length of the capillary loop 
(0.284±0.109mm) was found to be significantly longer as 
compared with those in healthy controls 
(0.199±0.072mm), (p<0.05). The mean capillary density 
in SSc patients (5.11±1.72 capillaries/mm; range 4-10) 
was found to be significantly lower as compared with 
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those in healthy subjects (10.3±0.59 capillaries/mm, 
range 10-12), (p<0.05). A prominent subpapillary plexus 
was found in 17% (8/36), which was significantly lower 
as compared with healthy volunteers (33.3%, 11/33), 
(p<0.05).   
In SSc patients with a duration of the disease less 
than 3 years (mean duration 1.8±0.9 years, range 0.75-3), 
in 50% of the cases (5/10) an “early” phase 
“scleroderma” type capillaroscopic pattern was found. It 
is characterized by the presence of dilated capillaries, 
single giant capillaries, single haemorrhages, without 
capillary loss and with relatively preserved distribution as 
mentioned above (Fig. 1). In the other 50% (5/10) of the 
patients from this group an “active” phase “scleroderma” 
pattern was observed (Fig. 2) with the characteristic 
features of this phase – frequent giant capillaries and 
haemorrhages, avascular areas and different degree of 
derangement. In the group of SSc patients with duration 
of the disease of more than 3 years (mean duration 
12.4±6.7 years, range 5-27), in 26.9 % (7/26) it was 
found a “late” phase “scleroderma” capillaroscopic 
pattern, characterized by presence of extensive, “desert-
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like” avascular areas, neoangiogenic capillaries, severe 
derangement, absence of giant capillaries and 
haemorrhages (Fig. 3). In 61.5% (16/26) of the patients 
from this subgroup, an “active” phase “scleroderma” type 
capillaroscopic pattern was found, in 7.7% (2/26) - an 
“early” phase and in 3.8% (1/26) - the images were not 
evaluated because of poor visualization.  
 
 
 
Fig. 1. “Scleroderma” type capillaroscopic pattern, an 
“early” phase; D-dilated capillaries, G – giant capillaries, 
H – haemorrhage. 
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Fig. 2. “Scleroderma” type capillaroscopic pattern, an 
“active” phase; G – giant capillaries, AA - avascular area. 
 
Fig. 3. “Scleroderma” type capillaroscopic pattern, a 
“late” phase; AA – avascular area, N – neoangiogenic 
capillaries.  
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1.2. Association between capillaroscopic pattern 
and presence of digital ulcers in systemic sclerosis 
Digital ulcers at the hands were present in 36.1% 
(13/36) of the SSc patients. In all of them (13/13), an 
“active” phase “scleroderma” pattern was observed, 
characterized by presence of frequent giant capillaries, 
haemorrhages and avascular areas (Fig. 4). An “active” 
phase “scleroderma” pattern was found and in other 
73.9% (17/23) of patients without digital ulcers (p>0.05). 
 
Fig. 4. “Scleroderma” type capillaroscopic pattern, an 
“active” phase of the finger with active digital ulcer; G - 
giant capillaries, H - haemorrhage, PO – pericapillary 
oedema.  
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1. 3. Capillaroscopic pattern of the toes in 
systemic sclerosis patients 
100% (36/36) of the patients reported about 
symptoms of RP in the hands and 94.4% (34/36) reported 
episodes of RP in the feet, but the difference was not 
significant (p>0.05). In the vast majority of patients with 
RP symptoms of both hands and feet, the symptoms were 
more severe at the hands (82%, 28/34). Digital ulcers of 
the fingers were found in 36% (13/36) of the cases and in 
8.3% (3/36) in the toes (p<0.05). The skin score of the 
hands and fingers (2.05±0.67) was significantly higher 
than that in the feet (0.69±0.57), (p<0.05). 
Nailfold capillaroscopy of the hands of the SSc 
patients showed the classic “scleroderma” type 
capillaroscopic pattern in 97.2% (35/36), with the typical 
features - dilated and giant capillaries, haemorrhages, 
avascular areas and neoangiogenesis. In contrast, in the 
toes, the “scleroderma” type capillaroscopic pattern was 
found only in 66.7% (24/36) of the patients, and this 
difference in frequency of the specific changes of the 
fingers and toes was statistically significant (p<0.05), 
(Fig. 5,6,7). 
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With respect to distinct differences, in the toes, 
the dilated capillaries were found in 72.2% (26/36) of the 
cases, giant capillaries - in 30.6% (11/36), haemorrhages 
- in 8.3% (3/36), avascular areas - in 41.7% (15/36), and 
neoangiogenesis - in 22.1% (8/36). This difference in 
frequency of the distinct capillaroscopic parameters in 
the toes and fingers of SSc patients was statistically 
significant for all parameters (Fig. 8, Table 2). 
In addition, the mean values of the arterial 
diameter, the venous diameter, and the capillary length 
were statistically significantly higher in the fingers when 
compared with the respective values of the toes. The 
mean capillary density was found to be significantly 
lower in the hands compared with those of toes (p<0.05), 
(Table 3).  
When comparing the mean values of the main 
capillaroscopic parameters in the toes of the SSc patients 
with those of the toes of healthy controls, it was observed 
that the mean diameter of the arterial and the venous 
capillary limb was significantly wider in SSc patients 
(p<0.05). The mean capillary length was found to be 
longer in SSc patients compared with those in healthy 
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individuals, but the difference did not reach statistical 
significance (p>0.05). Furthermore, the mean capillary 
density of the toes of SSc patients was found to be 
significantly lower (7±3 capillaries/mm) than that of the 
toes of healthy volunteers (10±1.13 capillaries/mm), 
(p<0.05), (Fig. 9, Table 4). 
 
 
 
Fig. 5. “Scleroderma” type capillaroscopic pattern, an 
“active” phase of the toe of 48-year-old male patient with 
limited form of SSc; G - giant capillaries, H - 
haemorrhages, AA – avascular area. 
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Fig. 6. “Scleroderma” capillaroscopic pattern, an “active” 
phase of the finger of the same patient, presented at  
Fig. 5; G - giant capillaries, H - haemorrhage, AA – 
avascular area.  
 
Fig. 7. The frequency of the “scleroderma” type 
capillaroscopic pattern of the fingers (blue column) and 
toes (red column) in SSc patients.  
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Fig. 8. The frequency of the distinct abnormal 
capillaroscopic parameters in the context of the 
“scleroderma” type pattern in the fingers (blue column) 
and toes (red column) of SSc patients.   
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Table 2. The frequency of the capillaroscopic parameters 
of the “scleroderma” type pattern in the fingers and toes 
of SSc patients.   
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Table 3. Comparison of the mean values of the main 
capillaroscopic parameters in the fingers and toes of SSc 
patients. 
 
 
Fig. 9. Normal capillaroscopic pattern of the toe of a 
healthy volunteer. 
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Table 4. Comparison of mean values of the main 
capillaroscopic parameters at the toes of SSc patients and 
at the toes healthy volunteers.  
 
 2. Capillaroscopic pattern in systemic lupus 
erythematosus 
RP was found in 73% (22/30) of the cases in the 
group of patients with SLE, and in 10% (3/30) vasculitis 
of peripheral vessels was presented. The most frequent 
capillaroscopic changes in SLE patients were the 
presence of elongated capillaries in 43% (13/30), an 
increased tortuosity in 70% (21/30) and a prominent 
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subpapillary plexus in 60% (18/30) of the cases. In 80% 
(24/30) of the patients, dilated capillaries were found, in 
6.6% (2/30) - giant capillary loops and in 16.6% (5/30) -  
haemorrhages. The mean capillary diameters of the 
arterial (0.019±0.006mm) and the venous limb 
(0.027±0.007mm) in the examined group of patients were 
significantly wider than the values in age and sex-
matched healthy controls (0.012±0.001mm for the 
arterial limb and 0.017±0.002mm for the venous limb 
respectively), (p<0.05). The mean capillary length in 
SLE patients (0.245±0.111mm) was found to be longer 
than those in healthy controls (0.199±0.071), but the 
difference was not statistically significant (p=0.0505). 
The mean capillary density in SLE patients (8±1.46 
capillaries/mm) was significantly lower than those in 
healthy subjects (10±0.59 capillaries/mm), (p<0.05).  
In 50% of the patients a “SLE” type 
capillaroscopic pattern (with elongated capillaries, 
increased tortuosity, dilated capillaries and prominent 
subpapillary plexus) was found (Fig.10). Positive tests 
for ANA were detected in 73.3% (11/15) of the patients 
with “SLE” type capillaroscopic pattern. In 54% (6/11) 
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the ANA titer was ≥1:640. In 40% (6/15) of the patients 
with “SLE” type capillaroscopic pattern positive tests for 
antibodies against extractable nuclear antigens were 
found, as follows: in 40% (6/15) positive tests for anti-
dsDNA, in 33% (5/15) for anti–Ro antibodies, in 20% 
(3/15) for anti-RNP antibodies. Antiphospholipid 
antibodies (anticardiolipin antibodies - IgG and IgM and 
β-2 glycoprotein IgG and IgM classes) were negative in 
patients with a “SLE” type capillaroscopic pattern.  
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Fig. 10. “SLE” type capillaroscopic pattern in SLE 
patient with secondary RP, demonstrating dilated and 
elongated capillaries, increased tortuosity, prominent 
subpapillary plexus, magnification 200x; D – dilated 
capillaries, El – elongated capillaries, T – tortuous 
capillaries, PP - prominent subpapillary plexus. 
 
In 30% (9/30) of the cases, the capillaroscopic 
examination revealed “nonspecific changes”, which 
included some of the above-mentioned changes (Fig. 11).  
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Fig. 11. Nonspecific capillaroscopic changes in SLE 
patient without RP, demonstrating dilated (D) and 
tortuous capillaries (T), magnification 200x.  
 
In 6.6% (2/30) of the patients it was found a 
normal capillaroscopic pattern and in 13.3% (4/30) a 
“scleroderma-like“ pattern (Fig. 12). In all the patients 
with “scleroderma-like” capillaroscopic findng positive 
autoantibodies with a high titer were found (Table 5), 
without signs for overlap with other CTD. In two out of 
four patients with such capillaroscopic findings a 
vasculitis of peripheral vessels was evident. 
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Fig. 12. “Scleroderma-like” capillaroscopic pattern in 40 
year-old-female patient with active vasculitis of 
peripheral vessels and high immunologic activity (case 2, 
presented in Table 5), magnification 200x; G – giant 
capillaries, H – haemorrhage. 
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Table. 5. Immunologic profile in SLE patients with a 
“scleroderma-like” pattern. 
 
The presence of a “scleroderma-like” 
capillaroscopic pattern is associated in the current 
litearture with presence of anti-RNP antibodies and 
overlap syndrome [47,56,66,80]. In the examined group 
of SLE patients such changes were observed in 4 
patients, all of whom demonstrated high immunologic 
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activity, but without signs for overlap with other CTD. 
Active vasculitis of peripheral vessels was evident in 2 of 
them.  
 
3. Capillaroscopic pattern in undifferentiated 
connective tissue disease 
RP was found in 77% (24/31) of the patients from 
this group. A “scleroderma-like” pattern was found in 
38% (12/31) of the patients with UCTD (Fig. 13). In 51% 
(16/31) of the patients from this group, “nonspecific” 
capillaroscopic findings were observed e. g., dilated, 
elongated and tortuous capillaries either alone or in 
different combinations without any specific 
capillaroscopic pattern.  In 9.6% (3/31) of the patients, a 
normal capillaroscopic pattern was found. The mean 
diameters of the arterial (0.020±0.007mm) and venous 
limb (0.028±0.012mm) in patients with UCTD were 
significantly wider as compared with the respective 
values in healthy controls (0.013±0.001mm for the 
arterial limb and 0.018±0.001mm for the venous limb 
respectively), (p<0.05). The mean length of the capillary 
loop in UCTD patients (0.234±0.090mm) was found to 
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be significantly longer as compared with those in healthy 
controls (0.197±0.070mm), (p<0.05). The mean capillary 
density in patients with UCTD (8.2±1.5 capillaries/mm; 
range 5-12) was found to be significantly lower as 
compared with those in healthy subjects (10±0.59 
capillaries/mm), (p<0.05).  
 A part of patients with UCTD (over ¼ to 1/3) 
develop a distinct rheumatic disease during the follow-
up, predominantly SSc, SLE or RA, but in the vast 
majority the clinical and laboratory findings remain 
unchanged in the scope of the term “UCTD” [101]. For 
evaluation of the predictive value of capillaroscopic 
pattern for the development of a distinct rheumatic 
disorder in patients with UCTD, a longer period of 
follow-up is necessary.  
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Fig. 13. “Scleroderma-like” capillaroscopic pattern in 
patient with UCTD and secondary RP, magnification 
200x; D – dilated capillaries, G – giant capillaries.  
 
4. Capillaroscopic pattern in inflammatory 
arthritis  
4. 1. Capillaroscopic pattern in rheumatoid 
arthritis 
 RP was found in 30.6% (19/62) of the patients 
with RA, and vasculitis of peripheral vessels – in 3% 
(2/62) of the cases. The most frequent findings at nailfold 
capillaroscopic examination were prominent subpapillary 
plexus in 69% (40/62) and elongated capillaries in 58% 
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(36/62). They were found statistically significantly more 
frequent in RA patients as compared with healthy 
controls (p<0.05), (Fig. 14). The mean capillary length in 
RA patients (0.265±0.086mm) was significantly longer 
than those in healthy individuals (0.216±0.081mm), 
(p<0.05). The diameters of the arterial (0.018±0.005mm) 
and the venous limb of the capillary loops (0.028 ± 
0.009mm) in patients with RA and secondary RP were 
found to be significantly wider as compared with RA 
patients without RP (0.016±0.003mm for the arterial limb 
and 0.022±0.005 for the venous limb), (p<0.05). On the 
other hand, dilated capillaries were found not only in RA 
patients with RP (78.9%; 15/19), but also in RA patients 
without clinical symptoms of vasospasm of peripheral 
vessels (62.8%; 27/43), (p<0.05), (Fig. 15, 16). The 
diameters of the capillary loops of RA patients without 
secondary RP were also significantly wider than those of 
healthy controls (0.012±0.001mm for the arterial limb 
and 0.017±0.002mm for the venous limb respectively), 
(p<0.05), (p<0.05), which may be associated with 
endothelial damage in different mechanisms in these 
patients. In 14.5% (9/62) of the RA patients, a 
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“scleroderma-like” pattern was observed (2 males and 7 
females). In one of these cases, an overlap of RA with 
SLE, secondary RP and secondary vasculitis was found. 
In the rest, 8/9 patients, no overlap with other CTD was 
evident. In all RA patients with “scleroderma-like” 
capillaroscopic pattern (9/9), a secondary RP was 
present, and in 2/9 - a secondary vasculitis respectively.  
 
Fig. 14. Comparison of the frequency of the elongated 
capillaries and the prominent subpapillary plexus in RA 
(blue column) and in heathy subjects (red column). 
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Fig. 15. Capillaroscopic pattern in RA patient without 
RP, magnification 200x; PP - prominent subpapillary 
plexus, dotted arrows – elongated capillaries.  
 
Fig. 16. Capillaroscopic pattern in RA with secondary 
RP, demonstrating presence of dilated capillaries 
(arrows), magnification 200x.  
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4. 2. Capillaroscopic pattern in psoriatic arthritis  
In 30.2% (11/34) of the cases with PsA, RP was 
present. The mean capillary length in PsA patients 
(0.166±0.09mm) was found to be significantly lower as 
compared with healthy individuals (0.209±0.07mm), 
(p<0.05). The mean capillary density was significantly 
lower in PsA patients (8±1capillaries/mm) as compared 
with healthy individuals (10.2±0.62capillaries/mm), 
(p<0.05). In patients with PsA, capillaries with specific 
morphology - tight terminal convolutions were found in 
58.8% (20/34) of the cases (Fig. 17). The finding is 
analogous to the vascular morphology in the psoriatic 
plaque. At Fig. 18 the capillary morphology of an active 
psoriatic plaque is demonstrated. The capillaries are 
visualized as terminal convolutions, while in the area of 
unaffected skin, adjacent to the psoriatic plaque their 
shape is like dot or comma (Fig. 19). Of note, tortuous 
blood vessels have been also observed at arthroscopic 
examination of the inflamed synovium of knee joint of 
PsA patients [45].    
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Fig. 17. Capillaroscopic pattern in PsA patient with 
involvement of hand joints, demonstrating tight terminal 
convolutions (arrows), magnification 200x.  
 
Fig. 18. Capillaroscopic picture of classic active, 
clinically evident psoriatic plaque, localized at the 
forearm, that demonstrates terminal convolution of the 
capillaries of the psoriatic plaque, magnification 200x 
(Videocap 3.0). 
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Fig. 19. Capillaroscopic picture of skin area, unaffected 
from psoriatic lesion, adjacent to the zone with psoriatic 
plaque, that is presented at Fig. 18. The picture 
demonstrates skin capillaries with normal morphology, 
that are visualized like dot or comma, magnification 200x 
(Videocap 3.0). 
 
 
4. 3. Capillaroscopic pattern in early arthritis 
We have found RP in 44% (4/9) of the examined 
patients with early symmetric arthritis, who were 
diagnosed as RA at the follow-up (7 patients with CCP-
positive and RF-positive and 2 patients with seronegative 
RA). At the capillaroscopic examination, a  normal 
capillaroscopic picture was observed in 66% (6/9) and 
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moderately dilated capillaries in 22.2% (2/9). A 
“scleroderma-like” pattern was found in 11.1% (1/9) of 
the patients with early arthritis, who presented with 
complaints of RP. The low frequence of the last type of 
capillaroscopic pattern in RA requires patients with such 
changes to be observed during the regular follow-up for 
the development of systemic rheumatic disease different 
from inflammatory arthritis.  
 
 5. Capillaroscopic pattern in other rheumatic 
diseases 
5. 1. Capillaroscopic pattern in primary 
Raynaud’s phenomenon 
  In 96.6% (30/31) of the patients with primary RP 
moderately dilated capillaries were observed. A normal 
capillaroscopic picture is one of the diagnostic criteria for 
primary RP. The mean capillary diameter of the arterial 
and the venous limb in patients with primary RP were 
found to be significantly wider as compared with healthy 
controls, which was easily detected by the software for 
quantitative assessment. The mean diameters of the 
arterial (0.018±0.004mm) and the venous limb 
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(0.026±0.006mm) were significantly wider as compared 
with those of healthy volunteers (0.012±0.001mm for the 
arterial limb and 0.017±0.002 for the venous limb), 
(p<0.005), (Fig. 20). The mean capillary density in 
primary RP (8.86±1.10 capillaries/mm, range 7-11) was 
significantly lower than those in healthy volunteers 
(10.34±0.59 capillaries/mm), (p<0.005). In one patient 
(3.2%) with primary RP with 51 years’ history for 
vasospastic attacks, giant capillaries, haemorrhages and 
avascular areas were observed, but without clinical and 
laboratory signs for CTD. The finding is probably 
associated with microvascular abnormalities, that appear 
after the long duration of the processes of ischemia and 
reperfusion.   
   
5. 2. Capillaroscopic pattern in primary 
fibromyalgia 
RP was found in 65% (17/26) of patients with 
primary fibromyalgia. The most frequent finding in 
patients with primary fibromyalgia was the presence of 
moderately dilated capillaries in 85% (22/26) of cases, 
including patients with RP as well as patients without 
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peripheral vasospasm. The mean diameters of the arterial 
(0.017±0.004mm) and the venous limb 0.023±0.004 mm) 
in patients with primary fibromyalgia were significantly 
wider as compared with the respective values in healthy 
controls (0.013±0.001mm for the arterial limb and 
0.018±0.002mm for the venous limb), (p<0.05). The 
mean length of the capillary loop (0.183±0.054mm) was 
significantly lower as compared with those in healthy 
controls (0.199±0.074mm), (p<0.05). The mean capillary 
density in patients with primary fibromyalgia (9±1.1 
capillaries/mm; range 7-12) was found to be significantly 
lower as compared with those in healthy subjects 
(10±0.59 capillaries/mm), (p<0.05). In the group of 
primary fibromyalgia, signs of microangiopathy (giant 
capillaries, haemorrhages, avascular areas and 
neoangiogenesis) characteristic of CTD were not found 
(Fig. 21). 
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Fig. 20. Capillaroscopic pattern in primary RP, 
demonstrating moderately dilated capillaries (arrows), 
magnification 200x. 
 
Fig. 21. Capillaroscopic pattern in primary fibromyalgia, 
demonstrating moderately dilated capillaries (D) and 
tortuous capillaries (T), magnification 200x. 
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5. 3. Capillaroscopic pattern in paraneoplastic 
Raynaud’s phenomenon 
As the capillaroscopic pattern in paraneoplastic 
RP is not studied specifically and is not well-defined, to 
elucidate this problem, three patients with paraneoplastic 
rheumatic conditions are reported here. They manifested 
with severe secondary RP (one male with scleroderma-
like syndrome and two women with paraneoplastic DM). 
Cases are here presented with distinct emphasis on 
capillaroscopic findings.  
 Case 1 
 A 58-year-old male patient with 15 years’ 
duration of psoriasis and PsA. The patient has been 
treated with methotrexate (15 mg weekly). In the last 5 
years the patient reported about increasing severe digital 
ischemia with pallor, cyanosis, reactive hyperemia, pain 
and numbness during cold exposure. Skin thickening of 
the fingers had appeared during the last year. At clinical 
examination, acroosteolysis of some of the distal 
phalanges and sclerodactyly has been found without skin 
involvement proximal of the metacarpophalangeal joints, 
at the lower extremities, face or trunk (Fig. 22 and 23). 
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Computed tomography revealed a tumour in the middle 
lobe of the right lung with a diameter of 3 cm with 
metastases in the lymph nodes of the right hilus. The 
capillaroscopic examination revealed the classic 
“scleroderma” type pattern. Dilated and giant capillaries, 
single haemorrhages, slightly decreased mean capillary 
density, relatively preserved capillary distribution were 
observed. These features are specific for the “early” 
phase “scleroderma” type capillaroscopic pattern as 
mentioned above (Fig. 24).  
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Fig. 22. 58-year-old man with psoriasis, PsA, severe RP. 
Acroosteolysis of the distal phalanges (the most profound 
of the 2
nd
 and 3
rd
 right fingers) and sclerodactyly are 
demonstrated. 
 
Fig. 23. Hand X-ray of the same patient, presented at Fig. 
22. Acroosteolysis of the distal phalanges, the most 
profound of the 2
nd
 and 3
rd
 right fingers is demonstrated. 
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Fig. 24. An “early” phase “scleroderma” capillaroscopic 
pattern of the same patients, presented at Fig. 22 and 23. 
Presence of dilated (D), giant (G) capillaries, haemorrage 
(H), relatively preserved capillary density and 
distribution are demonstrated, magnification 200x.  
  
Case 2  
  A 48-year-old woman referred for consultation 
with a 5-month duration of proximal muscle weakness 
with abrupt onset, that progressed rapidly and confined 
the patient to the bed. The muscle weakness had 
appeared simultaneously with classic skin rash and 
severe RP. Chest computed tomography detected a round 
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formation in the right upper lobe and enlarged lymph 
nodes in the right hilus. The histological diagnosis of 
these lesions showed a differentiated papillar 
adenocarcinoma. The capillaroscopic examination 
showed frequent dilated and giant capillaries, 
haemorrhages and severe microvascular disarrangement - 
the so-called “scleroderma-like” pattern typical of the 
idiopathic forms of DM.  
 Case 3 
 A 56-year-old woman with a proven diagnosis of 
DM with secondary RP presented also in our outpatient 
clinic. One year later, a papillar carcinoma of the thyroid 
gland has been found and partial thyroidectomy was 
performed. The capillaroscopic examination revealed 
dilated and giant capillaries, elongated capillaries, 
decreased mean capillary density with avascular areas, 
severe microvascular disarrangement, single 
haemorrhages and a clear evidence for neoangiogenesis 
(Fig. 25). These capillaroscopic features characteristic of 
the “scleroderma-like” pattern in DM are 
indistinguishable from those in idiopathic DM as in the 
second case. 
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Fig. 25. Capillaroscopic pattern of 56-year-old woman 
with paraneoplastic DM associated with cancer of thyroid 
gland reveals dilated (D), giant (G) capillaries and 
neoangiogenesis (N); magnification 200x.  
  
6. Capillaroscopic pattern in arterial 
hypertension 
 In untreated AH patients, a lower mean capillary 
density at the forearm, at the dorsum of the middle 
phalanx and in the nailfold area has been observed as 
compared with healthy controls [4]. The data about the 
respective values in AH patients, who receive 
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antihypertensive drugs are sparse. In the examined group 
of AH patients 49% (17/35) received antihypertensive 
treatment with ACE-inhibitors, 5.7% (2/35) with 
angiotensin receptor blocker, 62.8% (22/35) - β-blockers, 
17 % (6/35) – calcium channel blockers, 25.7% (9/35) – 
diuretics and 2.8 % (1/35) – drug with a central nervous 
mechanism of action.  
The mean capillary density of the nondominant 
hand of AH patients was 7.70 ±0.97 capillaries/mm 
(range 6-9), which is significantly lower as compared 
with healthy volunteers (10.33±0.56 capillaries/mm, 
range 9-12), (p<0.05). The low mean capillary density 
was not associated with presence of avascular areas (Fig. 
26). Signs of microangiopathy e. g., giant capillaries, 
haemorrhages, avascular areas and neoangiogenesis were 
not found in patients with AH.   
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Fig. 26. Capillaroscopic pattern in patient with AH, 
demonstrating low mean capillary density per mm, but in 
each dermal papilla there is a capillary loop, without 
avascular areas, magnification 200x. 
 
7. Comparison of qualitative and quantitative 
analysis of capillaroscopic images in patients with 
rheumatic diseases and evaluation the reproducibility 
of the qualitative assessment performed by two 
different investigators 
The quantitative and qualitative analysis resulted 
in identical estimates in 74% (148/200) of the cases for 
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the detection of dilated capillaries, in 84% (168/200) for 
giant capillaries and in 91% (182/200) for the presence of 
avascular areas. The distribution of the equal estimates 
from the quantitative and qualitative analysis of the 
investigators, divided according to the diagnosis is 
presented in Table 6. In Table 7 the numbers of 
capillaroscopic images with presence and absence of 
dilated, giant capillaries and avascular areas, evaluated 
quantitatively and qualitatively respectively are shown. 
Using 2 test, the number of the images with presence 
and absence of a certain capillaroscopic parameter e. g., 
dilated, giant capillaries and avascular areas, evaluated 
quantitatively by investigator 1 and qualitatively by 
investigator 2, were compared. A statistically significant 
difference between the two methods for detection of 
dilated and giant capillaries was found (p<0.05), but no 
significant difference regarding the detection of avascular 
areas (p>0.05), (Table 7). The quantitative and 
qualitative methods were further compared for 
assessment of images with “scleroderma” and 
“scleroderma-like” type capillaroscopic pattern and from 
patients with primary RP. Among the analyzed images, 
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107 were from “scleroderma” and “scleroderma-like” 
type (73 from patients with SSc, 10 - from DM, 19 - 
UCTD and 5 patients with different form of overlap 
syndrome). 20 images were from patients with primary 
RP and showed the classic finding with presence of 
dilated capillaries, but without signs for 
microangiopathy. Results are presented in Table 8 and 9. 
Among the “scleroderma” and “scleroderma-like” 
images, we have again found a statistically significant 
difference between the quantitative and qualitative 
method for detection of dilated and giant capillaries 
(p<0.05), while for the presence of avascular areas the 
difference was not significant (p>0.05). Among the 20 
capillaroscopic images from patients with primary RP, 
the estimates for absence of giant capillaries and 
avascular areas were equal in 100% (p>0.05). For these 
group of capillaroscopic images, a statistically significant 
difference between the quantitative and the qualitative for 
the detection of dilated capillaries was not found 
(p>0.05).  
The qualitative assessment by two different 
investigators showed identical estimates as follows, 81% 
  108 
(164/200) for the presence of dilated capillaries, 89% 
(177/200) for the detection of giant capillary loops, 85% 
(172/200) for the presence of avascular areas and in 
100% (200/200) of the cases for the haemorrhages (Table 
10). The distribution of the equal estimates, divided 
according to the diagnosis is presented in Table 10. 
Using 2 test, the number of the images with presence or 
absence of a certain capillaroscopic parameter e. g., 
dilated, giant capillaries, haemorrhages and avascular 
areas, evaluated qualitatively by both investigator 1 and 
2, was compared. For the detection of dilated capillaries, 
a statistically significant difference between estimates of 
the two investigators was found (p<0.05), while for giant 
capillaries, avascular areas and haemorrhages the 
difference was not statistically significant (p>0.05). As 
the key capillaroscopic parameters for microangiopathy 
are giant capillaries, avascular areas, haemorrhages, their 
detection is of crucial importance for differentiation of 
primary RP from RP in the context of SSc and 
scleroderma-spectrum disorders. Thus, the non 
significant difference for qualitative detection of these 
capillaroscopic changes between two different 
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investigators demonstrates the high reproducibility of the 
qualitative assessment for detection of microvascular 
damage in rheumatic disease irrespective of the 
examiner. Here, we have to emphasize that haemorrhages 
were the most reliable parameter that is evaluated equally 
in 100% of the cases. Results are presented in Table 11. 
We have further evaluated the reproducibility of the 
qualitative assessment between two different 
investigators in the different type of capillaroscopic 
images for the 107 capillaroscopic images from 
“scleroderma” and “scleroderma-like” type and and for 
the 20 images from primary RP. Results are presented in 
Table 12 and 13. Among the “scleroderma” and 
“scleroderma-like” images there were no significant 
difference between the estimates of the two investigators 
for all of the examined capillaroscopic changes e. g. 
dilated capillaries, giant capillaries, avascular areas, 
haemorrhages (p>0.05). Analogous results were achieved 
for the 20 capillaroscopic images from patients with 
primary RP that revealed 100% equal answers for 
absence of giant capillaries, avascular areas and 
haemorrhages. Regarding the detection of dilated 
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capillaries in these patients, no statistically significant 
difference between the estimates of the two investigators 
was found (p>0.05).  
The results of the study have shown, that 
qualitative assessment of the capillaroscopic parameters 
in patients with rheumatic diseases, is an adequate 
method for the everyday rheumatologic practice 
especially in cases with primary RP for exclusion 
presence of microangiopathy. No significant difference 
between qualitative and quantitative methods of 
assessment was found for detection of avascular areas. 
However, the quantitative analysis is more precise 
especially for detection of capillary dilation.  
 A good reproducibility of the qualitative 
evaluation, performed by two different investigators was 
found. It supports the idea, that interpretation performed 
by different investigators, who are experienced with 
capillaroscopic images in the context of rheumatic 
disease, produces results that can be reliably compared in 
the daily practice.  
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Table 6. The distribution of the equal estimates from the 
quantitative and qualitative analysis of the investigators, 
divided according to the diagnosis. 
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Table. 7. Comparison of number of images with presence 
or absence of a certain capillaroscopic parameter 
evaluated by investigator 1 (quantitatively) and 
investigator 2 (qualitatively). 
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Table 8. Comparison of number of images from 
“scleroderma” and “scleroderma-like” capillaroscopic 
patterns with presence or absence of a certain 
capillaroscopic parameter, evaluated by investigator 1 
(quantitatively) and investigator 2 (qualitatively). 
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Table 9. Comparison of number of capillaroscopic 
images of patients with primary RP with presence or 
absence of a certain capillaroscopic parameter, evaluated 
by investigator 1 (quantitatively) and investigator 2 
(qualitatively). 
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Table 10. The distribution of the equal estimates from the 
qualitative analysis of the two investigators, divided 
according to the diagnosis.  
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Table. 11. Comparison of number of images with 
presence or absence of a certain capillaroscopic 
parameter, evaluated by both investigator 1 and 2 
qualitatively. 
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Table 12. Comparison of the number of images from 
“scleroderma” and “scleroderma-like” capillaroscopic 
pattern with presence or absence of a certain 
capillaroscopic parameter, evaluated by both investigator 
1 and 2 qualitatively. 
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Table 13. Comparison of the number of capillaroscopic 
images of patients with primary RP with presence and 
and absence of a certain capillaroscopic parameter, 
evaluated by both investigator 1 and 2 qualitatively. 
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CHAPTER V 
DISCUSSION 
1. Systemic sclerosis 
1. 1. Capillaroscopic pattern of the hands in SSc 
patients 
 The classic “scleroderma” type capillaroscopic 
pattern of the hands in SSc patients was observed in 
97.2% (35/36) of the cases. This result is confirmatory 
and is similar to those, obtained by Maricq et al. (1980), 
who found a high frequency of capillaroscopic 
abnormalities in SSc in 83-93% of cases with overt SSc 
[90]. The frequency of the specific capillaroscopic 
pattern in SSc in the current study is higher than those of 
other investigators. Bergman et al. (2003) observed 
“scleroderma” type capillaroscopic picture in 70.4% of 
the examined SSc patients [14], Nagy et al. (2004) - in 
87.5% of the patients with diffuse form of SSc and in 
61.6% of the cases with limites form of the disease [101]. 
In the examined group of SSc patients in the present 
study an abnormal “scleroderma” type capillaroscopic 
pattern was observed in the hands in all but one female 
patient with limited SSc, who did not maintain the 
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obligatory period of 1 month without cutting her 
nailfolds and presented at the consultation with recent 
manicure. The data from the current study confirm the 
high frequency of the microvascular damage in SSc and 
the specific capillaroscopic findings at capillaroscopic 
examination of the nailfold area of the fingers in SSc 
patients.  
In SSc patients with a duration of the disease less 
than 3 years, in 50% of the cases (5/10) an “early” phase 
“scleroderma” capillaroscopic pattern was found. In the 
other 50% (5/10) of the patients from this subgroup an 
„active“ phase „scleroderma“ type capillaroscopic pattern 
was observed. In this group of patients a “late” phase 
capillaroscopic changes were not found.  In the group of 
SSc patients with duration of the disease > 3 years, a 
“late” phase capillaroscopic pattern was found, while the 
frequency of “early“ phase capillaroscopic pattern in this 
group was only 7.7% (2/26). These results also confirm 
that capillaroscopic changes in SSc differ in different 
phases of the disease, although the duration of the disease 
is not the only determinant factor for their development. 
The activity of the disease and the level of different 
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angiogenic and angiostatic factors play different and still 
not clearly defined role for dynamic of capillaroscopic 
changes in the different phases of SSc.  
 
1.2. Association between capillaroscopic pattern 
and presence of digital ulcers in systemic sclerosis 
It has been previously speculated that the 
development of ulcerations in SSc may be associated 
with the presence of avascular areas at the 
capillaroscopic examination [2]. A significant association 
between presence of digital ulcers and the lower number 
of capillaries in the distal row, as well as with higher 
number of megacapillaries and higher loop diameter was 
observed [120].  
The results of the current study show that the 
presence of digital ulcers at the hands of SSc patients is 
strongly associated with an “active” phase “scleroderma” 
type capillaroscopic pattern of the finger with active 
digital ulcer. Such capillaroscopic changes were observed 
in all the patients with digital ulcers of the fingers (100%, 
13/13). The observation of an “active” phase 
“scleroderma” type pattern in patients without digital 
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ulcers may therefore be used in the future as a predictor 
for the development of trophic changes, an indicator for 
modulation of vasoactive treatment for prevention of 
development of digital ulcers and as an additional 
objective method for evaluation of the disease activity 
score in SSc. An extensive observation with regular 
capillaroscopic examinations, 3-4 times per year may 
detect the dynamics in morphology of nailfold capillaries 
during the course of the disease, and the time frame 
between the appearance of an “active” phase 
capillaroscopic pattern and the development of digital 
ulcers.  
 
1. 3. Capillaroscopic pattern of the toes in 
systemic sclerosis  patients 
Symptoms of RP of the feet were found in a high 
proportion of the examined SSc patients (94. 4%). These 
results are similar to those of La Montagna et al., who 
have found presence of RP in 90% of cases among the 
examined 100 SSc patients. Digital ulcers of the fingers 
were found in 36% (13/36) of cases and in 8.3% (3/36) in 
the toes. This percentage is lower than those of La 
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Montagna et al., who reported necrotizing RP with a 
frequency of 52% in the hands and 31% in the feet [76]. 
While the specific “scleroderma” type 
capillaroscopic pattern of the fingers of SSc patients 
facilitates the early diagnosis, the capillaroscopic pattern 
of the toes has not been studied in the current 
rheumatology. The results from the current study 
demonstrate that capillaroscopic pattern of the toes of 
SSc also shows the characteristic features of 
microangiopathy in 66.7% of the examined group. This 
frequency is significantly lower than those of hands (97. 
2%, p<0.05). The abnormal “scleroderma” type 
capillaroscopic pattern was observed in the hands in all 
but one female patient with limited SSc, who did not 
maintain the obligatory period of 1 month without cutting 
her nailfolds and presented at the consultation with recent 
manicure. Capillaries in the distal row could not be 
visualized in this patient and the picture was hazy with 
traumatic haemorrhages. However, at the capillaroscopic 
examination of the toes of this patient, the classic 
“scleroderma” type capillaroscopic pattern was observed.  
Another clinical situation in SSc patients, in which 
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capillaroscopic examination of the fingers is impeded are 
severe contractures. Examination with a 
videocapillaroscope, designed as a microscope is here 
impossible. In contrast, it can be performed with devices, 
that are constructed with contact probe like those, which 
was used in the present study. In these difficult 
circumstances, capillaroscopic examination of the toes may 
offer an opportunity for assessment of microcirculation as it 
also reveals specific microvascular changes and thus 
possesses diagnostic potential although to a lower extent. 
The suggested use of nailfold capillaroscopy in patients with 
RP and suspected or established SSc is presented at Fig. 27. 
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Fig. 27. Suggested use of nailfold capillaroscopy in 
patients with RP and suspected or established SSc. 
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2. Capillaroscopic pattern in systemic lupus 
erythematosus 
The registered frequency of RP in the group of 
SLE patients was 73%, which is higher than those 
reported by the other authors in the current literature, 
varyng from 10 to 45% [17,74].  
The results from the study demonstrate that 
capillaroscopic examination is useful for the evaluation 
of microcirculation in SLE, especially those with 
secondary RP, but microvascular changes may be also 
observed in the absence of RP. In addition, a correlation 
between the abnormal capillaroscopic changes e. g. 
“SLE” and “scleroderma-like” type and the 
immunological activity of the disease was found.  
The presence of “scleroderma-like” 
capillaroscopic pattern is associated in the current 
litearture with the presence of anti-RNP antibody and 
overlap syndrome [47,56,67,81]. In the current study, 
such changes were found in 4 patients, all of whom 
demonstrated high immunologic activity, but without 
signs of overlap with other CTD. Anti-RNP antibody was 
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positive in 3 among the 4 patients with such 
capillaroscopic changes without signs for overlap 
syndrome. Active vasculitis of peripheral vessels was 
evident in 2 of them. Thus, it can be concluded that a 
“scleroderma-like” capillaroscopic pattern in SLE 
patients is not obligatory associated with overlap 
syndrome with other CTD. Such kind of capillaroscopic 
abnormalities may be observed in patients with active 
vasculitis of peripheral vessels as well as in patients with 
severe secondary RP and high immunologic activity.  
 
3. Capillaroscopic pattern in undifferentiated 
connective tissue disease 
RP is a characteristic feature of UCTD. In the 
current study, RP was found in 77% (24/31) of the 
patients from this group. A “scleroderma-like”pattern 
was observed in 38% (12/31) of cases, “nonspecific” 
capillaroscopic findings - in 51% (16/31) and normal 
capillaroscopic pattern - in 9.6% (3/31). Dynamic follow-
up would reveal the predictive value of capillaroscopic 
pattern for the development of a distinct rheumatic 
disorder in patients with UCTD, particularly 
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scleroderma-spectrum disorder or SLE in patients with 
more profound microvascular changes, observed at 
capillaroscopic examination. 
 
4. Capillaroscopic pattern in inflammatory 
arthritis 
4. 1. Capillaroscopic pattern in rheumatoid 
arthritis  
RP was found in 30.6% (19/62) of the patients 
with RA and in 3% (2/62) - a vasculitis of peripheral 
vessels was present. The results from the study show 
higher prevalence of RP in RA in comparison with the 
currently published literature data of other authors, who 
report varying, but significantly lower frequency from 
2.7 to 17.2% [27,54,117]. 
The most frequent findings at nailfold 
capillaroscopic examination were prominent subpapillary 
plexus in 69% (40/62) and elongated capillaries in 58% 
(36/62). The diameters of the arterial and venous limb of 
the capillary loop were significantly wider in patients 
with RA and secondary RP as compared with RA 
patients without RP. On the other hand, dilated 
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capillaries were found not only in RA patients with RP 
(78.9%, 15/19), but also in RA patients without clinical 
symptoms of vasospasm of peripheral vessels (62.8%, 
27/43). The diameters of the capillary loops in RA 
patients without secondary RP were also significantly 
wider than those of healthy controls, which may be 
associated with endothelial damage in different 
mechanisms in these patients in the context of the chronic 
inflammation. In 14.5% (9/62) of RA patients a 
“scleroderma-like” pattern was observed, 7 females and 2 
males. Only in one of these cases an overlap of RA with 
SLE was found. A secondary RP and a secondary 
vasculitis were evident in this patient. In the rest patients 
with such capillaroscopic changes (8/9), no overlap with 
other CTD was found. In all the patients with 
“scleroderma-like” pattern (9/9), a secondary RP was 
present, and in 2/9 - a secondary vasculitis respectively. 
This suggests that “scleroderma-like” capillaroscopic 
pattern may be observed in RA patients although with 
low frequency and its presence is not obligatory 
associated with overlap syndromes. These findings are 
not reported by other authors in the current 
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rheumatologic literature.   
 
4. 2. Capillaroscopic pattern in psoriatic arthritis  
It is an interesting fact, that in the group of 
patients with PsA, RP was observed in 30.2% of the 
cases, which is a finding analogous to the frequency of 
RP in RA patients in the current study (30.6%). There are 
no available systemic studies in the current literature, that 
address the frequency of RP in PsA. The association 
between psoriasis, PsA and RP is reported as individual 
cases as well as the association of psoriasis and PsA with 
autoimmune disease like SSc, SLE, etc. [58,114].  
In PsA patients, a significantly lower mean 
capillary length and mean capillary density was found as 
compared with healthy individuals. In patients with PsA, 
capillaries with specific morphology - tight terminal 
convolutions were present in a high proportion of the 
patients. This finding is analogous to the vascular 
morphology in the psoriatic plaque. The capillaroscopic 
examination of the uninolved from psoriatic lesions skin, 
in the areas adjacent to the psoriatic plaques, showed 
normal capillary morphology. Interestingly, in contrast to 
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the increased vascularity in the psoriatic plaque and the 
synovium in PsA, in the area of the nailfold the mean 
capillary density was found to be significantly lower as 
compared with those in healthy individuals.  
Of note, it has been found that vascular 
proliferation in the inflamed synovium in the knee joint 
of patients with PsA also is characterized with tortuous 
vessels, while the arthroscopic view of the inflamed 
synovium in RA reveals straight branching vessels. 
These specific vascular morphology in the psoriatic 
plaque, nailfold area and imflamed synovium in PsA is a 
hint for vascular pathology in this rheumatic entity [45]. 
In addition, the distinct differences between PsA and RA 
both at capillaroscopic examination and at arthroscopy 
are clues for pathogenetic differences between the two 
types of arthritis and possible distinct therapeutic 
approach in the future.  
 
4. 3. Capillaroscopic pattern in early arthritis 
The presence of RP in patients with early arthritis 
requires exclusion of SSc or SLE. In the group of patients 
with early arthritis, RP was present in 44% (4/9) of the 
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examined patients with early symmetric arthritis, who 
were diagnosed as RA at the follow-up. A “scleroderma-
like” pattern was found in 11.1% (1/9) of patients with 
early arthritis, who presented with RP. The low 
frequency of this type of capillaroscopic pattern in RA 
requires patients with such changes to be observed during 
regular follow-up for the development of systemic 
rheumatic disease different from inflammatory arthritis.  
In conclusion, in patients with early arthritis 
capillaroscopic examination is helpful for the differential 
diagnosis. The place of nailfold capillaroscopy in the 
management of patients with early arthritis and 
symptoms of RP is presented at Fig. 28.  
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Fig. 28. The actual status of nailfold capillaroscopy in the 
management of patients with early arthritis and 
symptoms of RP.  
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5. Capillaroscopic pattern in other rheumatic 
diseases 
5. 1. Capillaroscopic pattern in primary 
Raynaud’s phenomenon  
The absence of an abnormal capillaroscopic 
pattern is one of the diagnostic criteria for primary RP 
(Le Roy and Medsger) [79]. In the current study, a 
significantly wider mean capillary diameter of the arterial 
and the venous limb was found in almost all of primary 
RP patients (96.6%) as compared with healthy controls. 
These changes can be easily detected with the software 
programme for quantitative analysis. The capillary 
dilation, that is almost an obligatory finding in these 
patients, is probably a consequence of the recurrent 
processes of ischemia and reperfusion, that causes 
dysregulation of the vascular tone and permanent 
capillary dilation.   
In one female patient with primary RP with 51 
years’ duration of vasospastic attacks, an abnormal 
capillaroscopic pattern (giant capillaries, haemorrhages 
and avascular areas) was observed with negative 
immunologic tests and no other signs for CTD. As a 
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possible explanation of this finding the long duration of 
ischemia and reperfusion and the subsequent 
microvascular injury may be considered. This finding 
leads to the conclusion, that interpretation of the 
capillaroscopic findings is only in the concrete clinical 
situation.  
Of note, abnormal capillaroscopic pattern in 
patient with short duration of symptoms of RP or with 
late age of onset of the first symptoms should be strongly 
considered as a hint of systemic diseases.  
The place of nailfold capillaroscopy in the 
management and follow-up of patients with signs of RP 
is presented at Fig. 29 and 30.  
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 Fig. 29. The place of nailfold capillaroscopy in the 
management of patient with symptoms of RP. 
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Fig. 30. The actual role of nailfold capillaroscopy in the 
management of patients with RP according to the 
observed capillaroscopic changes. 
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5. 2. Capillaroscopic pattern in primary 
fibromyalgia  
 The frequency of RP in primary fibromyalgia is 
significant, which suggests, that the capillaroscopic 
pattern in these clinical entity schould be evaluated. In 
patients with primary fibromyalgia, significantly wider 
mean capillary diameters of the arterial and the venous 
limb were found as compared with healthy controls. 
These changes are similar to those observed in primary 
RP. The most frequent capillaroscopic finding in patients 
with primary fibromyalgia were moderately dilated 
capillaries in 85% (22/26) of the cases, that were found 
both in patients with and without symptoms of peripheral 
vasospasm. Capillaroscopic signs of microangiopathy 
characteristic of CTD were not observed in patients with 
primary fibromyalgia.  
 The capillaroscopic findings in primary 
fibromyalgia are analogous to those in primary RP. In the 
pathophysiology of fibromylagia, the combination of 
interactions among external stressors, behavioral 
constructs, neurotransmitters, hormones, immune and 
sympathetic nervous system seems to be involved. 
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Sympathetic dysfunction could explain the main features 
of fibromyalgia, such as sleep disorders, anxiety, RP or 
pseudo-RP, sicca syndrome, and intestinal irritability 
[43] as well as the respective changes in the 
capillaroscopic picture. Interestingly, the characteristic 
capillaroscopic changes for primary fibromyalgia, that 
are moderately dilated capillaries, may be observed both 
in patients with and without RP. The dysfunction of 
sympathetic nervous system, that causes dysregulation of 
vascular tone is a possible explanation of this finding. It 
probably produces the symptoms of RP in a high 
proportion of patients with primary fibromyalgia. In the 
cases without classic history of vasospastic attacks 
probably the sympathetic dysfunction cause processes of 
pseudo-RP with intermittent, but recurrent dysregulation 
of vascular tone, that results in a permanent moderate 
capillary dilation in these patients.  
  
5. 3. Capillaroscopic pattern in paraneoplastic 
Raynaud’s phenomenon  
Analysis of the capillaroscopic pattern in the 
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presented cases with paraneoplastic RP illustrates clearly 
the problem that capillaroscopic patterns in 
paraneoplastic RP in the context of scleroderma-like 
syndrome and DM appear to be indistinguishable from 
the microvascular changes in the respective idiopathic 
rheumatic diseases. It is well-known that late age at onset 
of RP is often in the context of systemic disease, that 
might also be a neoplastic process. If the suspicion for 
neoplastic condition is high, the patient should be 
screened as in every other routine case with 
paraneoplastic condition. Here, the capillaroscopic 
examination can not contribute to the differential 
diagnosis as the capillaroscopic features of 
microangiopathy are morphological and do not differ 
irrespective of the diffent starting causative factors in 
paraneoplastic and idiopathic systemic rheumatic 
diseases.  
 
6. Capillaroscopic pattern in arterial 
hypertension  
In AH patients, who receive antihypertensive 
drugs, the mean capillary density was found to be 
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significantly lower as compared with healthy volunteers. 
The low mean capillary density was not associated with 
presence of avascular areas, which confirms that reduced 
capillary density in these patients is structural and 
precedes the development of AH. Signs of 
microangiopathy e. g., giant capillaries, haemorrhages, 
avascular areas and neoangiogenesis, which are 
characteristic of CTD, were not found in patients with 
AH.   
 
7. Comparison of qualitative and quantitative 
analysis of the capillaroscopic images in patients with 
rheumatic diseases and assessment of the 
reproducibility of the qualitative evaluation of the 
capillaroscopic parameters, performed by two 
different investigators 
The qualitative analysis is more simple, accessible 
and fast for everyday application. The results from the 
study have shown, that qualitative assessment of the 
capillaroscopic parameters in patients with rheumatic 
diseases is an adequate method for the everyday 
rheumatologic practice, especially in cases with primary 
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RP for exclusion presence of microangiopathy. However, 
the quantitative analysis is more precise especially for 
detection of capillary dilation.  
Results from the study demonstrate a good 
reproducibility of the qualitative evaluation, when 
performed by two different investigators. They suggest 
that interpretation, performed by different investigators, 
who are experienced with capillaroscopic images in the 
context of rheumatic disease, produces results that can be 
reliably compared in the daily practice.  
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8. Conclusions and original contributions 
8. 1. This is the first study addressing the 
capillaroscopic patterns of the toes of patients with SSc. 
Although better protected from exposure to low 
temperatures, toes are affected from vasospastic attacks 
in the majority of patients. The capillaroscopic 
examination of the toes also reveals the specific for SSc 
“scleroderma” type capillaroscopic changes, but their 
frequency is significantly lower as compared with those 
of the fingers, which is probably also related to less 
severe RP and to a lower skin score in the feet. 
Therefore, the results from the study not only illustrate 
the systemic vascular pathophysiology of SSc, but also 
reveal the distinct differences of “similarly” affected 
vessels in different parts of the body. With respect to the 
clinical practice, examination of the toes could be 
considered to be added to the algorithm of a 
capillaroscopic evaluation of microcirculation in these 
patients, especially when SSc is suspected, but 
capillaroscopic examination of the fingers is hampered 
by different factors. 
 8. 2. An association between an “active” phase 
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“scleroderma” type pattern and the presence of digital 
ulcers of the hands of SSc patients was observed. This 
finding suggests a prognostic potential of this type of 
pattern to predict development of trophic changes, to 
serve as an indicator for modulation of vasoactive 
treatment and as an additional objective method for 
evaluation of the disease activity score in SSc.    
8. 3. In SLE patients, it has been found that 
capillaroscopic examination reveals microvascular 
changes also in the absence of RP.  
Here, the results from the study illustrate the 
correlation between capillaroscopic changes and 
immunological profile.  
Although the presence of a “scleroderma-like” 
capillaroscopic pattern is associated in the current 
literature with the presence of anti-RNP antibody and 
overlap syndrome, in the present study such changes 
were found in 4 patients, all of whom demonstrated high 
immunologic activity, but without signs for overlap with 
other CTD. These changes were found in the context of 
active vasculitis of peripheral vessels and in cases with 
secondary RP with high immunologic activity. Thus, it 
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could be concluded that the “scleroderma-like” 
capillaroscopic pattern in SLE patients is not obligatory 
associated with an overlap syndrome with other CTD.  
8. 4. This is the first extensive study of 
capillaroscopic pattern in RA with and without RP. 
Nailfold capillaroscopy revealed characteristic changes in 
patients with RA both with and without RP. Dilated 
capillaries are observed both in patients with and without 
RP. Presence of capillary dilation in the absence of 
vasospastic attacks is associated with endothelial damage 
that develops in different mevchanisms in the context of 
chronic systemic inflammation.  
For the first time in the literature it is reported, 
that “scleroderma-like” capillaroscopic pattern may be 
observed in RA patients although with low frequency, 
and these microvascular changes are also not obligatory 
associated with overlap syndrome with other CTD. 
8. 5. This is the first extensive study for 
evaluation the role of the capillaroscopy in patients with 
other inflammatory arthritis e.g., PsA and early arthritis. 
Nailfold capillaroscopy revealed characteristic changes in 
the RA-like form of PsA and in the subtype of the disease 
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with involvement of the distal interphalangeal joints.  
In patients with early arthritis, the capillaroscopic 
examination may facilitate differential diagnosis.  
Results from the present study confirm the 
necessity for inclusion the nailfold capillaroscopy in the 
diagnostic algorithm in patients with inflammatory 
arthritis.   
8. 6. Capillaroscopic pattern in cases of 
paraneoplastic RP was reported and it was demonstrated 
that in paraneoplastic scleroderma-like syndrome and 
DM capillaroscopic changes are analogous to those in the 
idiopathic forms of the diseases. The capillary changes 
are morphological and although caused by different 
factors in idiopathic and paraneoplastic rheumatic 
conditions, they do not differ. 
8. 7. New insights about capillaroscopic pattern in 
primary RP are given in the current dissertation. It has 
been demonstrated that a nonsignificant dilation of 
capillary loops detected by the software for quantitative 
assessment is almost an obligatory finding in patients 
with primary RP. On the other hand, in patients with long 
duration of primary RP, an abnormal capillaroscopic 
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pattern (giant capillaries, haemorrhages and avascular 
areas) may be observed without other signs for CTD.  
8. 8. New insights about capillaroscopic pattern in 
primary fibromyalgia are given in the dissertation. It has 
been concluded, that moderate capillary dilation may be 
observed in these patients in the context of dysregulated 
vascular tone due to sympathetic nervous system 
dysfunction. Of note, these changes are observed both in 
patients with symptoms of RP as well as in those without 
history for classic RP, that is probably related to pseudo-
RP process at the level of small blood vessels in the 
context of sympathetic dytsregulation. These 
capillaroscopic changes are analogous to those in primary 
RP. No signs of microangiopathy were found in primary 
fibromyalgia patients.  
8. 9. The analysis of capillaroscopic pattern in 
patients with AH, who receive antihypertensive 
treatment, showed that the mean capillary density is 
significantly lower as compared with healthy individuals, 
but these findings are not associated with presence of 
avascular areas or other major signs of microangiopathy. 
Capillaroscopic changes are morphological and the 
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antihypertensive treatment does not influence them.  
 8. 10. In the current study, it has been 
demonstrated, that the qualitative assessment of 
capillaroscopic parameters in patients with rheumatic 
diseases is a reliable method for the everyday 
rheumatologic practice especially in cases with primary 
RP to exclude presence of microangiopathy. However, 
the quantitative analysis is more precise especially for 
detection of capillary dilation.  
Results from the present study demonstrate also a 
good reproducibility of the qualitative evaluation, 
performed by two different investigators.  
 8. 11. The results from the dissertation will 
facilitate the establishment of the capillaroscopic 
examination in unclear clinical situations of the 
rheumatologic practice.   
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CHAPTER VI 
 SUMMARY 
Nailfold capillaroscopic examination is a 
noninvasive technique with a substantial potential for the 
evaluation of the acral microcirculation in vivo. In 
addition, it is the only available technique for an on-
demand analysis of the nutritional capillaries. At present, 
the main indication for capillaroscopic examination in 
rheumatology is the presence of RP. The method is 
currently applied for differentiation of primary RP from 
RP in the context of SSc and other scleroderma-
spectrum-disorders. However, the sparse knowledge 
about specific capillaroscopic patterns in other rheumatic 
diseases and the absence of guidelines for analysis of 
capillaroscopic images are still limiting factors for 
application of nailfold capillaroscopy in the everyday 
practice when diagnosing rheumatologic patients 
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Therefore, this thesis addresses novel aspects of 
the application of nailfold capillaroscopy in 
rheumatology.  
Chapter 1 provides an overview of the current 
application of nailfold capillaroscopy and includes the 
analysis of the actuality of the subject. Chapter 2 
addresses the aim and tasks of the dissertation and 
Chapter 3 presents the materials and methods included 
in the dissertation. The study includes 297 patients with 
rheumatic diseases, who were examined during routine 
in- and outpatient consultation at the Chair for Internal 
Medicine and Rheumatology in the Justus-Liebig-
University Giessen, Department of Rheumatology and 
Clinical Immunology, Kerckhoff Clinic, Bad Nauheim. 
The investigated patient groups consisted of 36 SSc 
patients, 30 SLE patients, 31 patients with UCTD, 62 RA 
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patients, 9 patients with early arthritis, 34 patients with 
PsA with a RA-like form and with a subtype of the 
disease with involvement of the distal interphalangeal 
joints, 31 patients with primary RP, 26 patients with 
primary fibromyalgia, 3 patients with paraneoplastic RP, 
35 patients with essential mild-to-moderate AH without 
systemic rheumatic disease and control group with 42 
healthy volunteers without known disease, who did not 
receive medications. Nailfold capillaroscopy was 
performed with a commercially high-end 
videocapillaroscope (Videocap 3.0, DS Medica, Italy). 
The findings were analysed qualitatively and 
quantitatively and were compared with clinical, 
laboratory and immunological data of the patients. 
Based on the results of the examinations of the 
thesis, the following novel contributions have been 
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achieved: analysis and characterization of the 
capillaroscopic pattern of the toes of SSc patient, 
capillaroscopic pattern in the primary fibromyalgia, RA 
with and without RP, early undifferentiated arthritis, 
paraneoplastic RP, AH patients, who receive 
antihypertensive therapy. In addition, the qualitative and 
quantitative methods for evaluation of capillaroscopic 
images have been evaluated (Chapters 4 and 5).  
In conclusion, it could be demonstrated that 
nailfold capillaroscopy is a method that provides valuable 
and valid information in several common rheumatic 
diseases with and without symptoms of peripheral 
vasospasm. Therefore, the results from the dissertation 
will contribute to the establishment of capillaroscopic 
analysis in hitherto uncharacterized clinical situations in 
the rheumatologic practice.   
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ZUSAMMENFASSUNG 
Die Nagelfalz-Kapillarmikroskopie ist eine 
nichtinvasiv und mit wenig Zeitaufwand durchführbare 
Untersuchung zur Analyse der akralen Mikrozirkulation. 
Derzeit liegt das Haupteinsatzgebiet der 
Kapillarmikroskopie in der Differenzialdiagnose unklarer 
Durchblutungsstörungen bei entzündlich-rheumatischen 
und immunologischen Krankheitsbildern, vor allem bei 
prominentem Raynaud Phänomen. Hier wird die 
Kapillaroskopie in der Routineversorgung für die 
Differenzierung der primären und sekundären Formen 
des Raynaud Phänomens und zur Diagnosestellung bei 
systemischer Sklerose und Sklerodermie-ähnlichen 
Erkrankungen verwendet. Trotz der guten Verfügbarkeit 
der Kapillaroskopie gibt es nur wenige Erkenntnisse für 
kapillarmikroskopische Muster bei anderen 
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rheumatischen Erkrankungen und mit akralen Ischämien 
assoziierten Entitäten. In der vorliegenden 
Dissertationsarbeit wurden daher die Nagelfalz-
Kapillarmikroskopie Muster bei verschiedenen 
rheumatischen Erkrankungen im Detail analysiert. 
Kapitel 1 beinhaltet die Einführung und den Überblick 
über die aktuelle Verwendung der Kapillarmikroskopie 
in die Rheumatologie und die Einbindung in den 
aktuellen Stand des Wissens.  
Kapitel 2 legt die Ziele und die Aufgabenstellung der 
Dissertation dar, Kapitel 3 beschreibt die Patienten und 
Methodik. Die Studie umfasste 297 Patienten mit 
verschiedenen rheumatischen Erkrankungen, die am 
Lehrstuhl für Innere Medizin der Justus-Liebig 
Universität Giessen in der Abteilung für Rheumatologie 
und Klinische Immunologie, Kerckhoff Klinik, Bad 
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Nauheim untersucht wird: 36 Patienten mit systemischer 
Sklerose, 30 mit systemischen Lupus erythematodes, 31 
mit undifferenzierten Kollagenose, 62 mit rheumatoide 
Arthritis, 9 mit Früharthritis, 34 Patienten mit 
Psoriasisarthritis und peripherer Beteiligung, 3 mit 
paraneoplastischen Raynaud Syndrom, 31 Patienten mit 
primäres Raynaud Phänomen, 26 Patienten mit primäre 
fibromyalgie, 35 Patienten mit primäre arterieller 
Hypertonie ohne systemische rheumatische 
Erkrankungen (antihypertensiv behandelt) und 42 
gesunde Kontrollen. Die Nagelfalz-Kapillarmikroskopie 
wurde mit einem high-end Videokapillaroskop (Videocap 
3.0, DS Medica, Italien) durchgeführt. Die 
kapillarmikroskopischen Befunde werden quantitativ und 
qualitativ analysiert und mit klinischen und 
Laborbefunden verglichen.  
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 (Kapitel 4 und 5). Die Analyse der Daten zeigte, 
dass die Nagelfalzkapillaroskopie eine wertvolle 
diagnostische Methode in der Differenzialdiagnostik von 
verschiedenen rheumatischen Erkrankungen mit und 
ohne akrale Minderperfusion darstellt. Die Ergebnisse 
dieser Dissertation sollen auch mithelfen, die 
Frühdiagnostik rheumatischer Erkrankungen zukünftig 
zu verbessern und praxisnäher zu gestalten 
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